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ABSTRACT
This research project had two major goals. Selected
members of six groups of clinically useful drugs were
obtained to develop and optimize reverse-phase isocratic
high-performance liquid chromatographic (HPLO separations
using the Hewlett Packard Series 1090 M HPLC. All
optimized methods displaved excellent resolution between
compounds within a method. Each optimized drug assay
developed, displayed good linearity and precision.
The second and primary goal of this research project
was to provide RIT with a teaching tool. These optimized
separations were incorporated into six laboratory
experiments, written in a format that RIT's undergraduate
students of Medical Technology could easily follow and
complete in one. three hour student laboratory session.
Each laboratory experiment is characterized bv being a fast,
simple, easy, and reliable reverse phase isocratic HPLC
separation of select members of these drug groups that can
be identified and quantitated in serum or plasma.
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INTRODUCTION
A. Background
High-performance liquid chromatography (HPLC) is an
extremely useful and powerful analytical technique. There
are numerous applications of this technique in the field of
Clinical Chemistry. HPLC can be used to separate.
presumptively identify, and quantitate almost any molecule
that can be placed into solution. The major advantage of
HPLC over other chromatographic techniques are speed,
resolution, and high sensitivity. This technique is capable
of detecting nanogram quantities of a compound in solution.
The separation mechanism and detection techniques commonly
used are usually non destructive resulting in the potential
for collection of purfied sample fractions. HPLC has
analytical superiority over other methodologies which may
encounter difficulties from cross-reactivity with
structurally similar components present. It is often the
method of choice when there is a need to differentiate and
quantitate a parent drug from its' metabolites.
HPLC can be a valuable tool for the clinical
toxicologist . It has ability to aid in identification
and quantitation of pharmacological agents present in
complex matrices like body fluids.
Recent improvements in equipment engineering have
produced very reliable systems. Computer controlled systems
with autosamplers permit the analvsis of multiple samples
with little attention or intervention from the operator.
Major improvements in column packings have dramatically
increased column performance. Column selection has greatly
increased too. It is now easier for the analytical chemist
to exploit the chemical properties of structurally similar
compounds to achieve efficient separations in a reasonable
period of time. A single column can be used to provide
accurate and rapid analysis of numerous structurally similar
drugs present in complex matrices such as serum or plasma
with minimal sample clean-up or pretreatment .
B. Purpose
The purpose of this research project was to develop,
optimize, and validate HPLC separations of selected members
of six groups of commonly used drugs that could potentially
be identified and quantitated in serum or plasma. The drug
groups investigated included alkaloids, analgesics,
anticonvulsants, barbiturates, tricyclic antidepressants,
and xanthines. A complete list of the drugs for which
assays were developed is presented in Table I. The
selection of drugs were based on an interest in
investigating a large range of the most widelv used drugs
in terms of varying functional groups, polarities and
ionization constants.
A major focus of this research project, which has been
added as an addendum to this thesis, was to take these
optimized assays and write standard operating procedures
for each of the 6 drug groups studied. The title of these
student laboratory experiments are listed below.
Simultaneous Hi gh-Perf ormance Liquid Chromatographic
Analvsis of Alkaloids
Simultaneous Hi gh-Perf ormance Liquid Chromatographic
Analvsis of Analaesics
3. Simultaneous Hi gh-Perf ormance Liquid Chromatographic
Analvsis of Anticonvulsants
Simultaneous Hi gh-Perf ormance Liquid Chromatographic
Analysis of Barbiturates
5. Simultaneous Hi gh-Perf ormance Liquid Chromatographic
Analysis of Theophylline and Related Methyl xanthi nes
6. Simultaneous Hi gh-Performance Liquid Chromatographic
Analysis of Tricyclic Antidepressants
TABLE I
List of Drugs Chromatoqraphed
1) . Alkaloids
a. Hvdromorphone
b . Quini ne
c. Codeine
d. Cocaine
e. Strychnine (internal standard)
2) . Anal aesi cs
a. Acetaminophen
b. Caffeine
c . Sal i cvl i c Acid
d. Acetyl sal i cyl i c Acid (Aspirin)
e. Phenacetin (internal standard)
3) . Anticonvulsants
a. Primidone
b. Phenobarbi tal
c. Diphenylhydantoi n
d. Carbamazepi ne
e. Ethosuximide
f- Hexobarbitol (internal standard)
4) . Barbi turates
a. Barbital
b. Phenobarbi tal
c. Butabarbital
d. Amobarbital
e. Secobarbital
f- Hexobarbital (internal standard)
5) . Theophylline and Related Methyl xanthi nes
a. Theobromine
b. Theophylline
c. Caffeine
d. ft-Hydroxyethyl theophyl 1 i ne (internal
standard )
6) . Tricyclic Antidepressants
a. Doxepin
b. Ami tri ptyl ine
c. Imipramine
d. Nortriptyline
e. Desipramine
f- Trimipramine
g. Promazine (internal standard)
C. The Reverse-Phase Separation Mode
All separations presented in this research paper were
achieved using reverse-phase high-performance liauid
chromatography (RP-HPLC). This mode is a type of partition
chromatography which relies upon the separation or
partitioning of solutes, such as drugs, between two
immiscible solvents. A kev to the definition of RP-HPLC
is that one is using a mobile phase solvent, often called
the eluent, that is more polar than the stationary phase.
One solvent is chemically bonded to a stationary column
packing. The other solvent is the mobile phase that is
pumped across the stationary bed and which can selectively
elute retained solutes.
D. Stationary Bonded Phases
This type of chromatography is also called bonded phase
high-performance liquid chromatography due to the fact that
a liquid phase (adsorbent) is covalently bonded to the
silica support. Common adsorbents include octadecyl (C18),
octyl (C8>. butyl (C4), cvano (CN) . and amino (NH2)
groups. All the bonded stationary phases that were used in
this research project were manufactured from bare rigid
silica. The exact process used bv the manufacturer of
these column packings is proprietary information. The
general chemistry of the bonding process is known. Usually
the bonded phases are chemically added to the reactive
silica support through a silylation or Grignard reaction.
Chemical bonding of a functional group such as a C1B or C8
hydrocarbon to the surface silanol groups reduces the
column's polarity. Functional groups such as an alkyiamine
or alkvlnitrile are used to moderate surface polarity.
In order to obtain desired separation and resolution
of numerous components in a sample, one must know or be able
to deduce some of the solute's properties from its
structure. It is essential to know the compound solubility
characteristics. Separation of compounds in a mixture is
based on their selective retention on the stationary phase
used. The "like dissolves like" rule is a basic rule that
can help explain the interactions that occur in an HPLC
column. Nonpolar (hydrophobic) compounds separate best on
nonpolar stationary phases. Polar (hydrophi 1 i c > compounds
are best separated on polar stationary phases. There are
some limitations to these rules. A large nonpolar compound
with a large aliphatic side chain may be too strongly
retained on a C18 bonded phase. One may need to use a less
hydrophobic stationary phase. The CB or C4 bonded phases may
achieve the appropriate separation during a reasonable
period of time. Moderately polar compounds may not be well
retained on a C8 or C18 bonded phase. One may need to use
the moderately polar surface of an alkylnitrile bonded phase
to achieve the desired separation.
Due to steric hinderances, the bonding efficiency is
usually only 8-207.. Unreacted silanol groups can also be
"endcapped" by reacting exposed residual silanol groups
with a compound such as trimethyl chl orosi 1 ane to make the
surface of these stationary phases even less polar.
E. Column Selection
Column selection is a critical decision. There are many
manufacturers of columns and many types of columns to choose
from. A single column usually involves a sizable
investment. Careful selection of a column containing the
proper stationary phase is needed in order to achieve
optimal chromatographic separation of a sample containing
numerous structurally similar compounds. For this study
column selection was done after carefully reviewing the
published literature and searching existing manufacturer
catalogues. One can not always find columns and operating
parameters to exactly match all the reauired applications.
Based on current knowledge, one can hypothesize what would
be an appropriate column for the required separation.
There are many reports of reverse-phase separations of
alkaloids (1-5). analgesics (1, 6-16), anticonvulsants (1,
12, 16. 17-25,). barbiturates (1, 12, 19. 27-28). and
theophylline (1, 12, 16. 29-32). In the past, much of
RP-HPLC was done on C18 columns. With appropriate
adjustments to the mobile phase const i tutents, it is often
possible to achieve similar separations on CB columns
resulting in markedly reduced total analysis time.
In the past, many researchers have assayed tricyclic
antidepressant drugs using normal phase chromatography
(33-36). The stationary phase used consisted of silica.
The recent literature reports several markedly improved
reverse-phase separations of these compounds (1, 2, 37).
These drugs are secondary and tertiary amines which make
these compounds difficult to separate on C8 and C18
stationary phases. The best separations are achieved on
alkylnitrile bonded phase columns operated in the reverse-
phase mode.
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There are many other important parameters to consider
when selecting an HPLC column. The type of solid support
holding the bonded phase can be important. Particle size
typically ranges from 3 pm to 10 urn. The smaller the
particle size of the solid support, the larger the total
surface area of the adsorbent. This will often times
improve column efficiency- Improved resolution and capacity
at the expense of longer analysis time and higher column
back pressures can be expected. The shape of the solid
support particle can be spherical or irregular. Irregularly
shaped silica packings have higher surface area, and greater
ef f i ci ency .
Spherical shaped supports have comparatively lower
surface area and a lower percentage of carbon loading.
Therefore, spherically shaped column packings usually have
comparatively lower efficiencies and relatively shorter
analysis times. If higher efficiencies are not needed,
spherically shaped supports offer the advantage of good
permeability which will reduce column equilibration time and
minimize column back pressure. This will prolong column
life and pump seals.
F. Mobile Phase Selection
HPLC in the reverse-phase mode usually implies that one
is using a relatively nonpolar stationary phase in
comparison with the eluent which is more polar. Often times
solvent pairs such as acetoni tri 1 e-water or methanol -water
are used. Since the solute and mobile phase solvent are in
competition for adsorption sites on the stationary bonded
phase, it is often necessary to mix water with organic
solvents of varying polarities to achieve the desired
partitioning effect in the column in order to selectively
elute and resolve components of interest from a mixture.
Small percentages of other solvents such as tetrahydrofuran,
2-propanol , or tri ethyl ami ne can be added as mobile phase
modifiers to slightly alter the polarity of the solvent or
modify the adsorptivity of a solute for the adsorbent. An
aqueous buffer may be added to the eluent to control pH and
thus suppress ionization.
Often, published literature and
manufacturers'
application bulletins can assist a researcher in acquiring a
reasonably good initial eluent system for the needed
separation. If the solute is too strongly retained on the
column, increasing the concentration of the organic
modifier in increments of 10-20"/. may help optimize the
10
separation. If the solutes elute too quickly, it may be
necessary to increase the concentration of the aqueous
component in the eluent system.
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II. EXPERIMENTAL
A. Instrumentation
A Hewlett-Packard (HP) Hi gh-Perf ormance liquid
chromatographic system was used for all analytical work.
The major components housed within the mainframe of this HP
1090 Series M liquid chromatograph were an HP 1040M
photodiode array detector, a PV5 ternary solvent delivery
system, and a Rheodyne model 7010 manual injection valve.
This system was controlled and monitored by an HP 79994A
Analytical Chemstation. The central part of this
Chemstation was the HP 9000 Series 300 computer. Other
important components included an HP 9153B 20 megabyte
Winchester disc drive with a separate disc drive for 3.5
inch flexible discs, an HP 35741A color video monitor,
keyboard, and HP 2225A Thinkjet printer. HP 79995A,
revision 3.11 operating software was also used. All of the
products were obtained from Hewlett-Packard Company,
Analytical Sales Office, Avondale, PA 19311.
12
B. Col umns
All HPLC columns used in this research project were
acquired from Alltech Associates, Inc., Deerfield, IL 60015.
The guard and analytical columns were acquired in the
cartridge format. Specific column descriptions are detailed
in the optimized chromatographic conditions section of this
report .
C. Reaaents
HPLC-grade water, acetoni tri 1 e, methanol, and
tetrahydrofuran used in this study were from standard
suppliers as was reagent grade glacial acetic acid and
potassium hydroxide. Tetrabutyl ammoni urn phosphate
(0.5 M TBA) , an ion pairing agent, was acquired from Regis
Chemical Company, Morton Grove, IL 60053. High purity
triethyl amine and monobasic potassium phosphate were
purchased from Sigma Chemical Company, ST. Louis, Mo 63178,
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P. Eluents
All eluents were prepared on a percent volume/percent
volume basis. All eluents were degassed under vacuum in a
sonic bath immediately prior to being used. The HP 1090 was
equipped with and eluent stabilization system, therefore all
eluents were sparged (bubbled a less-soluble gas into the
solvent) with helium for 20 minutes prior to pumping the
eluent through the system.
E. Method Development and Optimization
Development and optimization of the chromatographic
separations were carried out by a practical and empirical
approach. The elution efficiency and order of each member
of each drug group was initially tested with columns and
mobile phases suggested in the literature. This was done by
dissolving small quantities of each compound in methanol.
Injections of each component within a test group verified
the elution order and separation efficiency. Changes in
column type, solvent flow rate, detection wavelengths, as
well as eluent pH, ionic strength, and polarity were
14
required for optimization of separation. The modifications
in the separation parameters were accepted when the HPLC
parameters provided Gaussian shaped peaks with baseline or
near baseline separation between the 4 to 7 eluting
compounds of interest in each test group. Speed was
an exceptionally desirable characteristic. All the
optimized experimental parameters needed to assay the
6 drug groups considered in this report are presented in
Section F, Tables 2-7. A photocopy of a chromatogram of
each optimized separation is presented in Figures 1-6.
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F. Optimized Chromatographic Conditions
TABLE 2
Optimized Chromatographic Conditions for Alkaloids
Analytical Column All tech Adsorbosphere CN, 5ym
particle size, 250 mm X 4.6 mm i.d.
cartridge., C/N. 287195
Guard Column None
Eluent 207. buffer (0.02 M KH2P04, 0.005 M
tetrabutvl ammoni a phosphate,
pH 6. 1)
807. acetoni tri le
0.047. Tri ethyl amine
Fl ow 2. 5 mL/mi n
Pressure 149 bar
Detector UV. 235 nm
Injection Volume 100 uL
Run Time 6.0 mi n
Retention Times
(mi n >
Cocaine = 1 . 79
Codeine = 2.42
Hydromorphone = 2.96
Quinine = 3. 46
Strychnine = 5.08
_ _ .
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FIGURE 1
Optimized Chromatographic Separation of Alkaloids
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TABLE 3
Optimized Chromatographic Conditions for Analgesics
Analytical Column Alltech Econosphere C8, 5 pm
particle size 150 mm X 4.6 mm i.d.
cartridge C/N. 71012
Guard Alltech C8 cartridge C/N. 28017
Eluent 387. methanol
627. water with 17. acetic acid
Fl ow 1.0 mL/min
Pressure 180 bar
Detect i on UV. 254 nm
Injection Volume
Run Time
100 uL
7.5 mi n
Retention Time
(mi n >
Acetaminophen = 2.38
Caffeine = 3.42
Aspirin = 4.62
Salicylic Acid = 5.68
Phenacetin = 6.13
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FIGURE 2
Optimized Chromatographic Separation of Analgesic;
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TABLE 4
Optimized Chromatographic Conditions for Anticonvulsants
ll 1
Col umn
i
Alltech Econosphere C8, 5 pm
particle size, 150 mm X 4.6 mm i.d.
cartridge C/N. 35618
Guard Alltech C8 cartridge C/N. 28017
El uent 547. buffer (0.1 M KH2P04, pH 4.4)
467. methanol
Flow 1.5 mL/min
Pressure 246 bar
Detecti on UV, 210 nm
Injection volume 100 pL
Run time: 9.5 mi n
Retention Time
(mi n )
I
Ethosuximide = 2.01
Primidone = 2.56
Phenobarbi tal = 3.31
Hexobarbital = 6.11
Di phenyl hydantoin = 6.62
Carbamazepine = 8.35
__ 1
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FIGURE 3
Optimized Chromatographic Separation of Anticonvulsants
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TABLE 5
Optimized Chromatographic Conditions for Barbiturate;
Col umn Alltech Adsorbosphere HS C18, 7 pm
particle size, 150 mm X 4.6 mm i.d.
cartridge., C/N. 35616
Guard Alltech C18 cartridge., C/N. 28015
El uent 667. buffer (25mM KH2P04, pH 4.85)
277. acetoni tri le
77. methanol
Fl ow 2. 0 mL/mi n
Pressure 165 bar
Detecti on UV, 205 nm
Injection volume 100 uL
Run Time: 10.0 min
Retention Time Barbital = 1.59 min
Phenobarbi tal = 3.00 min
Butabarbital = 3.39 min
Hexobarbital = 5.87 min
Mephobarbi tal = 6.65 min
Secobarbital = 8.17 min
1
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FIGURE 4
Optimized Chromatographic Separation of Barbiturates
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TABLE 6
Optimized Chromatographic Conditions for Theophylline and
Related Methyl xanthi nes
Col umn Alltech Econosphere C8, 5 pm
particle size, 150 mm X 4.6mm i.d.
cartridge C/N. 71012
Guard Alltech C8 cartridge C/N. 28017
Eluent 947. buffer (10 mM KH2P04, pH 5.05) j
47. acetoni tri le |
27. tetrahydrof uran
Flow 1.5 mL/min
Pressure 168 bar
Detecti on UV, 210 nm
Injection volume 10 pL
Run Time 6.0 min
Retention Time
(min )
Theobromine = 2.64
Theophylline = 3.37
(3-Hydroxethyl theophyl 1 i ne = 3.74
Caffeine = 5.21
1
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FIGURE 5
Optimized Chromatographic Separation of Theophylline and Related
Methyl xanthines
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TABLE 7
Optimized Chromatographic Conditions for Tricyclic
Antidepressants
Column Alltech Econosphere CN, 5 pm particle
size, 150 mm X 4.6 mm i.d. cartridge,
C/N. 35621
Guard Alltech CN cartridge, C/N 28023
Eluent 437. methanol
407. acetoni tri le
177. buffer (0.012 M KH2P04, pH 6.7)
Flow 2. 5 mL/mi n
Pressure 141 bar
Detecti on UV, 215 nm
Injection volume 100 pL
Run Time 8.5 mi n
Retention Time
i
Trimipramine = 1.81 min
Doxepin = 2.20 min
Ami tri ptyl ine = 2.36 min
Promazine = 2.. 71
Imipramine = 2.93 min
Nortriptyline = 6.02 min
Desipramine = 7.43 min
. . ._j
26
FIGURE 6
Optimized Chromatographic Separation of Tricyclic
Antidepressants
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G. Standards and Precision Fluid'
1. Preparation of "Stock" Drug Standards
Drug standards needed for this research were purchased
from the Sigma Chemical Company, St. Louis, Mo 63178, in the
smallest and purest form available with the exception of
primidone and ethosuximide which were obtained from Alltech
Associates, Inc., Deerfield IL.
Separate stock (1.0 mg/mL) drug standards were prepared.
Methanol was the prefered solvent used to dissolve each of
the drugs used in this project although there were
exceptions. A (1.0 mg/mL) hexobarbital stock solution was
prepared in acetoni tri 1 e. All the stock (1.0 mg/mL)
analgesic solutions were prepared in their respective
chromatographic eluent (38:61 methanol : water with 17. acetic
acid) with the exception of theobromine which was soluble
at a concentration of 0.4 mg/mL .
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2. Preparation of "Working" Drug Standards
Working standards were prepared from stock standards by
diluting the appropriate stock standard. Within each of the
drug groups. 5 different levels of standards were prepared.
Within a drug group, precisely known volumes of the stock
standards were added to one of five class A 25 mL volumetric
flasks to achieve the desired concentrations.
A constant amount of internal standard was added to each
working standard to help adjust for minor fluctuation in
injection volumes that occurred when the manual sample
injector was used.
Due to the hazards of handling and storing human serum
and plasma, all drugs were assayed in a matrix that
resembled the particular chromatographic eluent as closely
as possible.
3. Preparation of the
"Working" Precision Fluids
Precision fluids were prepared from admixtures in the
identical way the working standards were prepared. Often
the drug concentrations were identical to working standards
level 2. 3, and 4.
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H. Method Validation
Within each drug group, 5 different levels encompassing
the reported reference concentration ranges in serum and
plasma were assayed. The reference ranges displayed in
Table 8 are an estimation of the concentration levels of
these drugs that one might expect to observe in serum or
plasma. Simultaneous calibration of each of the members of
each of the 6 drug groups was done by assaying 3 replicate
injections of each of the 5 "working" standards. Three
replicates per level were chromatographed . The
concentrations of each of the "working" standards prepared
and assayed are displayed in Tables 9-14.
To minimize errors in such variables as injection
volume, a constant amount of a compound with structure very
similar to the standards was added to each level.
Linearity of chromatographic responses of each of the
compounds of interest were evaluated by comparing the ratio
of integrated peak area of the standard over the integrated
peak area of the internal standard with respect to
increasing standard concentration. Linearity of
responses was evaluated using least squares linear
regression analysis (38). These integrated peak area
ratios of drug over internal standard were regressed upon
30
Table 8
Reported Reference Ranges for Human Serum and Plasma (39,40)
-_=
COMPOUNDS REFERENCE RANGE |
pg/mL 1
1) . Al kaloids
a. Cocaine 0. 10 0.50 |
b. Codei ne 0.01 0.07
c. Hydromorphone <0.03
d. Strychni ne (internal standard)
e. Qui nine ~ 7.0
2) . Anal gesi cs
a. Acetaminophen 10.0 30.0
b. Caf fei ne 3.0 15.0
c . Acetyl sal i cyl ic Acid < 200.0
d. Salicylic Acid < 200.0
f - Phenaceti n (internal standard)
3) . Anti convul sants
a. Ethosuximide 40.0 100.0
b. Pri mi done 5.0 10.0
c. Phenobarbi tal 15.0 40.0
d. Hexobarbi tal (internal standard)
e. Di phenyl hydantoin 10.0 20.0
f - Carbamazepi ne 8.0 12.0
4) . Barbiturates
a. Barbital < 200.0
b. Phenobarbi tal 15.0 40.0
c . Butabarbi tal < 30.0
d. Hexobarbi tal (internal standard)
e. Mephobarbi tal < 5.0
f . Secobarbi tal 1.0 2.0
5) . Theophylline and Xanthines
a. Theobromi ne ~ 5.0 20.0
b. Theophyl line 5.0 20.0
c . Beta-Hydroxyethyl theophyl 1 ine (internal standard)
d. Caffeine 3.0 15.0
6) . Tricyclic Antidepressants
a. Trimiprami ne 0. 150 0.250
b. Doxepin 0. 150 0.250
c. Ami triptyl ine 0.070 0.225
d. Promazine (internal standard)
e. Imipramine 0. 150 0.250
f . Nortriptyl ine 0.050 0. 150
g. Desiprami ne 0. 150 0.300
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TABLE 9
Working Standards used for Calibration of Alkaloids
(pg/mL)
Compound Level 1 Level 2 Level 3 Level 4 Level 5
Cocai ne 1.0 2.0 5.0 10.0 20.0
Codei ne 1.0 2.0 5.0 10.0 20.0
Hydromorphone 1.0 2.0 5.0 10.0 20.0
Qui nine 1.0 2.0 5.0 10.0 20.0
Internal standard 5.0 5.0 5.0 5.0 5.0
(Strychni ne)
TABLE 10
Working Standards used for Calibration of Analgesics
(pg/mL)
Compound Level 1 Level 2 Level 3 Level 4 Level 5
Acetaminophen 5.0 10.0 20.0 30.0 50.0
Caf f ei ne 2.0 5.0 10.0 20.0 25.0
Aspiri n 10.0 50.0 100.0 200.0 300.0
Salicylic Acid 10.0 50.0 100.0 200.0 300.0
Internal Standard 15.0 15.0 15.0 15.0 15.0
(Phenacetin)
32
TABLE 11
Working Standards used for Calibration of Anticonvulsants
(pg/mL)
Compound Level 1 Level 2 Level 3
r
Level 4
1
Level 5
Ethosux i mi de 10.0 25.0 50.0 100.0 150.0
Pri mi done 2.0 5.0 10.0 20.0 25.0
Phenobarbi tal 5.0 10.0 20.0 40.0 80.0
Di phenyl hydantoin 2.0 10.0 15.0 20.0 40.0
Carbamazepine 2.0 5.0 10.0 20.0 25.0
Internal Standard 20.0 20.0 20.0 20.0 20.0
(Hexobarbital )
il
TABLE 12
Working Standards used for Calibration of Barbiturates
(pg/mL)
Compound Level 1 Level 2 Level 3 Level 4 Level 5
Barbital 10.0 20.0 40.0 80.0 100.0
Phenobarbi tal 5.0 10.0 20.0 40.0 80.0
Butabarbital 10.0 20.0 30.0 40.0 50.0
Mephobarbi tal 1.0 3.0 5.0 8.0 10.0
Secobarbital 2.0 5.0 10.0 15.0 20.0
Internal Standard 20.0 20.0 20.0 20.0 20.0
(Hexobarbital >
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TABLE 13
Working Standards used for Calibration of Theophylline
and Related Methyl xanthi nes
(pg/mL>
Compound Level 1 Level 2 Level 3 Level 4 Level 5
Theobromi ne 2.0 5.0 10.0 20.0 25.0
Theophyl 1 i ne 2.0 5.0 10.0 25.0 50.0
Caf f ei ne 2.0 5.0 10.0 20.0 25.0
Internal Standard 15.0 15.0 15.0 15.0 15.0
(ft-Hydroxethyl-
theophyl 1 i ne)
TABLE 14
Working Standards used for Calibration of Tricyclic
Ant i depressants
(pg/mL)
Compound Level 1 Level 2 Level 3 Level 4 Level 5
Trimi prami ne 1.0 2.0 4.0 10.0 20.0
Doxepin 1.0 2.0 4.0 10.0 20.0
Ami tri ptyl ine 1.0 2.0 4.0 10.0 20.0
Imiprami ne 1.0 2.0 4.0 10.0 20.0
Nortri ptyl i ne 1.0 2.0 4.0 10.0 20.0
Desi pramine 1.0 2.0 4.0 10.0 20.0
Internal Standard 4.0 4.0 4.0 4.0 4.0
(Promazi ne)
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the drug standard's concentration. A summary of the
regression statistics, slope, y-intercept, correlation
coefficient, and standard error about the regression line
(Sy.x) for each compound are presented in Tables 15-20.
An estimate of total method imprecision at 3 different
levels for each drug was also done. The concentrations
selected included a low, medium, and high level within the
linearity ranges studied. Each of these 3 levels were
assayed 5 times. Summaries of the imprecision of each of
the compounds studied are presented in Tables 21-26.
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TABLE 15
Regression Statistics and Correlation
Alkaloids
Compound SI ope
Y
Intercept
Standard
Error of
Est imate
Correl ati on
Coef f i ci ent
Cocai ne
Codei ne
Hydromorphone
Qui ni ne
ii
0.4494
0.2149
0.2170
1 . 0683
-0.0065
0.0026
-0.0230
-0.0683
0. 1607
0.0575
0.0683
0.3841
0.9989
0.9994
0.9991
0.9988
TABLE 16
Regression Statistics and Correlation
Arlalgesi cs
\ Standard
Y Error of Correl ati on
Compound SI ope Intercept Estimate Coef f i ci ent
Acetami nophen 0. 1258 0.0483 0.0417 0.9998
Caf f ei ne 0.0433 -0.0004 0.0047 0.9999
Aspi r i n 0.0086 0.0114 0.0102 0.9999
Sal i cyl i c Aci d
i
0.0086 0.0131 0.0080 1 . 0000
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TABLE 17
Regression Statistics and Correlation
Anti convul sants
Standard
Y Error of Correl ati on
Compound SI ope Intercept Estimate Coef f i cient
Ethosuximide 0.0059 0.0006 0.0056 0.9999
Pri mi done 0.0717 0.0277 0.0185 0.9996
Phenobarbi tal 0. 1025 -0.0976 0. 1005 0. 9994
Di phenyl hydantoin 0. 1109 -0.0681 0.0913 0.9982
Carbamazepi ne
11 i
0. 1707 -0.0064 0.0286 0.9998
i _ ii
TABLE 18
Regression Statistics and Correlation
Barbi turates
Standard
"
Y Error of Correl ation
Compound Slope Intercept Estimate Coef f i ci ent
Barbital 0.0493 0.0150 0.0238 1.0000
Phenobarbi tal 0.0852 -0.0233 0.0409 0.9999
Butabarbi tal 0.0440 0.0102 0.0291 0.9991
Mephobarbi tal 0.0782 -0.0172 0.0177 0.9979
Secobarbi tal 0.0405 0.0009 0.0092 0.9995
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TABLE 19
Regression Statistics and Correlation
Theophylline and Related Methyl xanthi nes
Compound Slope
Y
Intercept
Standard
Error of
Estimate
Correl ati on
Coef f i cient
Theobromi ne
Theophyl 1 ine
Caf fei ne
0.0685
0.0673
0.0748
-0.0013
0.0114
0.0018
0.0131
0.0264
0.0124
0.9998
0.9998
0.9998
TABLE 20
Regression Statistics and Correlation
Tricyclic Antidepressants
Standard
Y Error of Correl ati on
Compound Slope Intercept Estimate Coef f i cient
Trimipramine 0.3881 0.0288 0.0705 0.9997
Doxepi n 0.6436 0.0002 0. 1098 0.9997
Ami triptyline 0.6005 -0.0314 0. 1179 0.9997
Imi prami ne 0.4175 0.0215 0.0446 0.9999
Nor tri ptyl i ne 0.6005 0.0006 0. 1444 0.9995
Desiprami ne
i
0.4306 0.0128 0.0684 0.9998
38
TABLE 21
Precision Data
(Drug Concentration, pg/mL)
Alkaloids
Compound Mean
Within-run (n = 5) Nominal Measured SD CV, 7.
Cocai ne
Low level 2.0 1.82 0.014 0.77
Medium level 5.0 5.07 0. 135 2.66
High level 10.0 10.56 0. 153 1.45
Codei ne
Low level 2.0 1.90 0.016 0.82
Medium level 5.0 4.93 0. 152 3.07
High level 10.0 10.36 0.206 1.99
Hydromorphone
Low level 2.0 1.60 0.048 3.03
Medium level 5.0 4.96 0. 124 2.50
High level 10.0 10.25 0.267 2.60
Qui ni ne
Low level 2.0 1.71 0.032 1.89
Medium level 5.0 5.09 0. 174 3.43
High level 10.0 10.41 0.309 2.97
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TABLE 22
Precision Data
(Drug Concentration, pg/mL)
Anal gesics
r
- - ~
i
Compound Mean
" '
Within-run (n = 5) Nomi nal Measured SD CV , 7.
Acetami nophen
Low level 10.0 9.95 0.005 0.05
Medium level 20.0 20.44 0.019 0.09
High level 30.0 29.45 0.052 0. 18
Caffeine
Low level 5.0 1.90 0.016 0.64
Medium level 10.0 10.07 0.007 0.07
High level 20.0 20. 13 0.039 0. 19
Aspi rin
Low level 50.0 50.40 0. 128 0.25
Medium level 100.0 100.21 0.340 0.34
High level 200.0 196.24 0.550 0.28
Salicylic Acid
Low level 50.0 50.50 0.032 0.06
Medium level 100.0 100.63 0. 160 0. 16
High level
1
200.0 198.00 0.540 0.27
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TABLE 23
Precision Data
(Drug Concentration, ug/mL)
Ant i convul sants
Compound
Withinrun (n = 5) Nomi nal
Mean
Measured SD CV. 7.
Ethosux i mi de
Low level
Medium level
High level
25.0
50.0
100.0
25.02
48.40
99.07
0.044
0.094
0.099
0. 18
0. 19
0. 10
Pri mi done
Low level
Medium level
High level
5.0
10.0
20.0
5.08
10.26
19.70
0.010
0.047
0.021
0.20
0.46
0. 11
Phenobarbi tal
Low level
Medium level
High level
10.0
20.0
40.0
10.70
19. 14
38.81
0.007
0. 008
0.028
0. 06
0.04
0.07
Di phenyl hydan toin
Low level
Medium level
High level
10.0
15.0
20.0
10.60
14.51
18.74
0.005
0.007
0.020
0.05
0.05
0. 11
Carbamazepine
Low level
Medium level
High level
i
5.0
10.0
20.0
4.94
10.25
19.85
0.008
0.008
0.015
0. 16
0.08
0.08
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TABLE 24
Precision Data
(Drug Concentration, pg/mL)
Barbiturates
1 1
Compound Mean
Within-run (n = 5) Nomi nal Measured SD CV, 7.
Barbital
Low level 10.0 10.62 0.306 2.88
Medium level 50.0 52.03 0. 188 0.36
High level 80.0 81.90 0.218 0.27
Phenobarbi tal
Low .1 evel 5.0 5.65 0.260 4.60
Medium level 25.0 24.92 0.080 0.32
High level 50.0 51.36 0.920 1.79
Butabarbital
Low level 5.0 4.82 0. 145 3.02
Medium level 25.0 24.80 0.081 0.33
High level 50.0 52.80 0.082 0. 16
Mephobarbi tal
Low level 1.0 1.05 0.039 3.72
Medium level 5.0 5. 14 0.013 0.26
High level
i
10.0 10.66 0.042 0.39
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TABLE 25
Precision Data
(Drug Concentration, pg/mL)
Theophylline and Related Methylxanthine;
Compound
Within-run (n = 5) Nomi nal
Mean
Measured
l n
SD CV, 7.
Theobromi ne
Low level
Medium level
High level
5.0
10.0
20.0
5.08
10.05
20.27
0.016
0.018
0.089
0.32
0. 18
0.44
Theophyl 1 ine
Low level
Medium level
High level
5.0
10.0
20.0
4.77
10.00
20.28
0.008
0.012
0.023
0. 17
0. 12
0. 11
Caf f ei ne
Low level
Medium level
High level
i
5.0
10.0
20.0
4.70
10.02
20.28
0.015
0.011
0.007
0.32
0. 11
0.04
i
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TABLE 26
Precision Data
(Drug Concentration. pg/mL)
Tricyclic Antidepressants
1 1
Compound
Within-run (n = 5) Nomi nal
Mean
Measured SD
l
CV. 7.
Tri mi pramine
Low 1 evel
Medium level
High level
2.0
4.0
10. 0
1 . 96
4.26
9. 79
0. 003
0. 015
0.051
0.15
0.35
0.52
Doxepin
Low level
Medium level
High level
2.0
4.0
10.0
2.01
4.21
9. 77
0.002
0.014
0.052
0. 10
0.33
0.53
Ami tri ptyl i ne
Low level
Medium level
! High level
2.0
4.0
10.0
2.03
4.20
9.70
0.002
0.014
0.052
0.09
0.33
0.54
Imipramine
Low level
Medium level
High level
2.0
4.0
10.0
1.95
4. 17
9.90
0. 002
0.010
0.048
0. 10
0. 24
0. 48
Nortriptyline
Low level
Medi um 1 evel
High level
2.0
4.0
10.0
2.05
4.24
9.63
0.005
0.021
0. 046
0.24
0.50
0.48
Desipramine
Low level
Medium level
High level
i _
2.0
4.0
10.0
2.02
4. 16
9-77
.,
0.017
0.026
0. 046
0.84
0.62
0. 47
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III. DISCUSSION
There is an increasing demand being placed upon
clinica-1 laboratories to perform more drug assays. The
need to verify positive results has become essential.
Often HPLC analysis can become the laboratories' reference
method, which can be used to recheck questioned results
obtained from faster, less specific assays. Properly
optimized HPLC assays can potentially be sensitive and
specific techniques for measuring drug serum and plasma
1 evel s.
All chromatographic separation methods described
within this paper display excellent performance. They are
simple to perform, easy to reproduce and were designed to
be used in an undergraduate student laboratory. All
methods display excellent linearity with correlation
coefficients approaching 1.0. All methods display
excellent precision over the concentration ranges studied,
with total variations of less than 5.07..
In most cases compounds were eluted i socrat i cal 1 y from
the columns using simple eluents. The chromatographic
separations of the anticonvulsants, barbiturates and
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tricyclic drugs investigated in this study were achieved
using simple acetoni tr i 1 e/methanol /buff er eluents. The
methyl xanthi nes were chromatographi cal 1 y separated
using 947. phosphate buffer with the addition of a small
percentage of acetonitrile and tetrahydrohydran as mobile
phase modifiers.
The eluent used to resolve the analgesics contained
methanol and reagent grade water containing a small amount
of acetic acid. The acetic acid was used to lower the
eluent pH in order to suppress ionization of these drugs to
facilitate separation and to increase the extinction
coefficients of the compounds at the detection wavelength.
It was difficult to find the appropriate mix of
solvents that would effectively elute the alkaloids in the
isocratic reverse phase mode. It was necessary to use an
eluent containing a phosphate buffer, acetonitrile,
tetrabutvl ammoni um phosphate, and tri ethyl ami ne to obtain
favorable equilibrium kinetics to achieve the acceptable
chromatographic separations observed.
One exceptionally nice component of the HPLC system
used was the photodiode array detector (DAD). This was a
high speed UV-VIS spectrophotometr i c detection device that
contains 211 photodiodes. These diodes are light sensitive
cells arranged in a row which are used to monitor incident
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radiaton from 190 nm to 600 nm simultaneously. Compounds
eluting from the column and traveling through the flow cell
can instaneously be photospectroscopi cal 1 y scanned. The
computer storage of this data can be recalled later and
studied to determine the optimum wavelength of detection
for an analyte.
One disadvantage of a photodiode array detector was
that they are typically less sensitive detectors compared
to variable and fixed wavelength detectors that use more
conventional photodetectors . It was easy to detect
analytes in the mg/mL range but it was not possible to
detect the alkaloid and the tricyclic anti depressent drugs
in the clinically relevant ng/mL range with this DAD.
This research was designed to provide RIT with a
teaching tool for the undergraduate students in Medical
Technology. HPLC is an extremely valuable analytical
technique. The 6 laboratory experimental protocols
written in the addendum of this thesis were written with
great individual attention. For the novice, HPLC can
initially appear to be a formidable task. Great care was
taken to write each laboratory as a separate unit, which if
followed carefully can be easily completed in a 3 hour
laboratory session with little supervision.
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A. Simultaneous Hi ah-Per f ormance Liauid Chromatographic
Anal ysi s of Alkaloids
1 . Introduct i on
1.1 Alkaloids are a group of organic bases with
complicated appearing cyclic structures. Cocaine,
morphine, quinine, and strychnine are among the
clinically significant alkaloids which can be
extracted from certain plants. Other important
alkaloids such as codeine and hydromorphone are
derivatives of morphine. Many of the alkaloids are
clinically useful since they have the ability to
produce analgesia (reduce pain). Some alkaloids
have other useful pharmacological properties.
Quinine will cause analgesia and antipyresis
(reduce fever), but is noted for its antimalarial
actions (41). Strychnine is a poison with no
therapeutic value. Though strychnine is used as a
rodenticide. it is interesting to note that it can
be found in adulterated "street drugs".
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2. Purpose
2.1 HPLC is a valuable analytical tool available for
the determination of blood and plasma levels of
alkaloids. The purpose of this laboratory
procedure is to familiarize the clinical chemistry
student with the basic operation of a semi-
automated high-performance liquid chromatograph so
that he can gain experience with this separation
technique and learn some practical analytical
skil Is.
Summary of Method
3.1 Cocaine, codeine, hydromorphone, quinine, and
strychine are dissolved in eluent and
chromatographed on an Alltech cyano-bonded phase
cartridge column. The separation is done
i socrati cal 1 y (a single eluent system), in the
reverse-phase mode using paired ion partition
chromatography. Mixtures of the drugs are
differentially partitioned on this column and
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clearly resolved. Spectrophotometr i c detection is
performed at 210 nm. Quantitation is done by
mathematically comparing detector response of drug
standards to unknowns. Strychnine, the internal
standard, is added to each sample at a constant
level so that small variations in technique, such
as injection, can be corrected.
Materials and Reagents
4. 1 Apparatus
4.1.1 A Hewlett-Packard high-performance liquid
chromatographic system was used for all
analytical work (Hewlett Packard,
Avondale, PA 19311-0900). The major
components housed within the mainframe of
this HP 1090 Series M liquid chromatograph
are an HP 1040M photodiode array detector, a
PV5 ternary solvent delivery system, and a
Rheodyne model 7010 manual injection valve.
This system is controlled and monitored by
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an HP 79994A Analytical Chemstation. The
central part of this Chemstation is the HP
9000 Series 300 computer. Other important
components included an HP 9153B 20 megabyte
Winchester disc drive with a separate disc
drive for 3.5 inch flexible discs, an HP
35741A color video monitor, keyboard, and an
HP 2225A Thinkjet printer. HP 79995A,
revision 3.11 operating software is also
used .
4.1.2 An Alltech Adsorbosphere CN. 5 pm 250 mm
X 4.6 mm i.d. cartridge column was used.
(Alltech Associates, Inc.. Deerfield. IL
60015.. C/N. 287195).
4.1.3 Ranin model P-100 and P-1000 digital
pipettes were used. (Ranin Instrument
Company Inc., Woburn, MA 01801).
4.2 Stock Reagents (All reagents are available from the
stockroom)
4.2.1 HPLC-grade acetonitrile (ACN).
4.2.2 HPLC-grade water.
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4.2.3 HPLC-grade methanol (MEOH).
4.2.4 HPLC-grade isopropyl alcohol (IPA).
4.2.5 Reagent grade monobasic potassium phosphate
(KH2P04) .
4.2.6 Tetrabutyl ammoni um phosphate (TBA) (Regis
Chemical Company. Morton Grove. IL 60053.
C/N. 680502) .
4.2.7 Tri ethylamine (TEA) (Sigma Chemical Company.
St. Louis, Mo 63178. Sigma No. T0886)
4.2.8 Cocaine HCL (Sigma Chemical Company.
Sigma No. C5776), .
4.2.9 Codeine (Sigma Chemical Company.
Sigma No. C5901 ) .
4.2.10 Hydromorphone HCL (Sigma Chemical Company
Sigma No. H5136) .
4.2.10 Quinine (Sigma Chemical Company. Sigma No.
Q1625.
4.2.12 Strychnine (Sigma Chemical Company. Sigma
No. S6876) .
4.3 Stock Buffer 0.02M KH2P04, 0.005M TBA, pH
6. 1 (ID .
4.3.1 Add 2.722 g of 0.02M KH2P04 to a IL
graduated cylinder.
4.3.2 Add 900 ml of HPLC-grade water.
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4.3.3 Add 10 mL of the stock 0.5M TBA.
4.3.4 Add HPLC-grade water to the IL mark.
4.3.5 Stir until completely dissolved.
4.4 Eluent (ID 207. stock buffer (Prepared in
section 4.3)
807. ACN
0.047. TEA
4.4.1 In a IL graduated cylinder, add 800 mL of
HPLC-grade ACN.
4.4.2 Add 200 mL of the buffer prepared in section
4.3.
4.4.3 Add 400 pL of TEA.
4.4.4 Mix well, place in a IL HP solvent reservoir
bottle and degas under vacuum in a sonic-
bath for 1 minute.
4.5 Column Storage Solution (ID 107. v/v ME0H
4.5.1 In a IL graduated cylinder, add 100 mL of
HPLC-grade ME0H.
4.5.2 Add HPLC-grade water up to the IL mark.
4.5.3 Mix well, place in a IL HP solvent reservoir
bottle and degas under vacuum in a sonic-
bath for 1 minute.
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5. Stock Standard'
5. 1 Cocaine Standard. 1.0 mg/mL (25 mL)
5.1.1 Weigh 28.0 mg of cocaine HCL into a 25 mL
class A volumetric flask.
5.1.2 Add eluent (prepared in section 4.4) to the
mark and dissolve completely.
5. 2 Codeine Standard, 1.0 mg/mL (25 mL)
5.2.1 Weigh 25.0 mg of codeine into a 25 mL
class A volumetric flask.
5.2.2 Add eluent (prepared in section 4.4) to the
mark and dissolve completely.
5. 3 Hydromorphone Standard. 1.0 mg/mL (25 mL)
5.3.1 Weigh 28.2 mg of hydromorphone HCL
into a 25 mL class A volumetric flask.
5.3.2 Add eluent (prepared in section 4.4) to the
mark and dissolve completely.
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5- 4 Quinine Standard. 1.0 mg/mL (25 mL)
5.4.1 Weigh 25.0 mg of quinine into a 25 mL class
A volumetric flask.
5.4.2 Add eluent (prepared in section 4.4) to the
mark and dissolve completely.
5- 5 Strychnine Internal Standard, 1.0 mg/mL (25 mL)
5.5. 1 Weigh 25.0 mg of strychnine into a 25 mL
class A volumetric flask.
5.5.2 Add eluent (prepared in section 4.4) to the
mark and dissolve completely.
6. Preparation of Working Alkaloid Standards for
Calibration (10 mL)
6. 1 Level 1, Cocaine, Codeine, Hydromorphone. Quinine.
at 2.0 ga/mL and Strychnine at, 5.0 pg/mL
6.1.1 Add 20 pL of each of the stock 1.0 mg/mL
cocaine, codeine, hydromorphone, and quinine
standards to a 10 mL class A volumetric
flask using an appropriate pipette.
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6.1.2 Add 50 pL of the stock 1.0 mg/mL
strychnine internal standard to this 10 mL
class A volumetric using an appropriate
pipette.
6.1.3 Add eluent (prepared in section 4.4) to the
10 mL mark. Mix by inversion.
6. 2 Level 2, Cocaine. Codeine, Hydromorphone. Quinine,
at 10.0 DQ/mL and Strychnine at. 5.0 ug/mL
6.2.1 Add 100 pL of each of the stock 1.0 mg/mL
cocaine, codeine, hydromorphone, and quinine
standards to a 10 mL class A volumetric
flask using an appropriate pipette.
6.2.2 Add 50 pL of the stock 1.0 mg/mL
strychnine internal standard to this 10 mL
class A volumetric using an appropriate
pi pette.
6.2.3 Add eluent (prepared in section 4.4) to the
10 mL mark. Mix bv inversion.
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7. Preparation of an "Unknown" Sample for Analvsis
7.1 Add 50 pL of each of the stock 1.0 mg/ml
cocaine, codeine, hydromorphone, and quinine
standards to a 10 mL class A volumetric flask using
an appropriate pipette.
7.2 Add 50 pL of the 1.0 mg/mL stock strychnine
internal standard to this 10 mL class A volumetric
flask using an appropriate pipette.
7.3 Add eluent (prepared in section 4.4) to the 10 mL
mark. Mix bv inversion.
8. Anal ysi s
8. 1 Equipment Set-up
8.1.1 HP1090M and Workstation should be correctly
installed, configured, and operational. If
the system is not operational, refer to the
appropriate
operators'
manuals (42-45).
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8.1.2 The solvent delivery system (SDS) should
already have been primed. If the solvent
system is not operational, refer to the
appropriate sections in the operator's
manual (46). This is usually done by pumping
degassed IPA through each solvent line at
5.0 mL/min for 3-5 minutes.
8.1.3 Load the degassed eluent prepared earlier
into the solvent compartment section
farthest to the left (pump A).
8.1.4 Install the appropriate cartridge column.
8. 2 Instrument Start-up
8.2.1 Turn on the electrical power to the
analytical workstation by switching on the
tan 6 outlet power strip located along the
wall behind the computer.
8.2.2 Turn on the electrical power to the
mainframe HPLC by pressing the POWER-ON
button located on the front panel in the
lower right corner.
8.2.3 Turn on the diode array detector (DAD) by
pressing the DETECT0R-0N button located
on the same panel. The deuterium lamp
All
requires 15-30 minutes warm-up time.
3.2.4 "urn or. the Think Jet Printer. (The switch
is located in the back right corner).
8.2.5 Turn on the 20 MB hard drive (9153B) by
depressing the rectangular button located in
front on the left side.
8.2.6 Turn on the CRT by depressing the
rectangular button located in front on the
lower left side.
8.2.7 Turn on the computer by depressing the
rectangular button located in the front on
the lower left side. Several screens
should automatically be displayed on the CRT
screen, indicating that memory is being
loaded, tested, and that the system is
booted.
8.2.8 The system should now be fully operational.
All operations and commands can now be
controlled from the keyboard. Please note
the keys labeled fl-f8 across the top of
the keyboard. They are essential to the
operation of this system and will be used
frequently to initiate operations described
in the green boxes viewed across the
bottom of the CRT screen. Each screen
viewed is called a form, which contains
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several functions that can be initiated
through commands from the keyboard.
8.2.9 Verify the correct date on the bottom of
the CRT screen. Proceed by pressing the
return key on the keyboard.
8.2.10 Verify the correct time. Proceed by
pressing the return key on the keyboard.
8.3 Getting Ready to Run an Analysis - You are now in
the [Top Level] of a hierarchial tree of
functions (See Form Al).
8.3.1 Press F2, CData Acquisition] to load the
data acquisition program.
8.3.2 The next screen (form) is the PREPARE TO
INJECT form (See Form A2) . Press F6, CEDIT
PARAMS].
8.3.3 You are now in the FILE INFORMATION form.
If the alkaloid parameter file is not loaded
(See Form A3), press Fl CLoad ParamsJ. You
will be prompted to type the name of a
parameter file (See Form A4) .
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FORM Al
HP 7 9 9 9 4 fl
HPLC WORKSTATION
for HP 1040M
and HP 1090M
Copyright 1985, HewJett-Packard Company
[TOP LEVEL]
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FORM A2
PREPARE TO INJECT
Data File Name : DATA:TEST1.D
Flow BKBg? 0.000 ml /min
Solvent Pi 108. 0 0.0 X
B 0.0 0.0 Z
CI 0.0 0.0 X
7 May 88 12:32 pm
overwri te
: narrow
Max Pressure : 400 1 bar
Stop Time : no limit 0.00 min
Contacts : 0000 0000
LC PRERUN
DAD PRERUN
I Star.kVRunS
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FORM A3
FILE INFORMATION
PARAMETER FILE
Param. File Name DATA:TEST.A
Last Change Date 10 Apr 88 2: 10 am
information :
Last_Altered By :
DATA FILE
Data File Name DATA: TEST l.D
Operator Name :
Sample Name :
Further Comments :
PARAMSi PARAMS
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FORM A4
FILE INFORMATION
PARAMETER FILE
Param. File Name
Last Change Date 10 Apr 88 2:10 am
2nformation :
Last Altered By :
DATA FILE
Data File Name DRTft: TEST1.D
Operator Name
Sample Name
Further Comments
Load Parameter File - Enter a File Name or type '?' to list a disc volume
Escape-
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8.3.4 Type DATA:ALKAL.A over the previously
loaded parameter file name. (See Form A5).
Press return. All the proper operating
parameters needed to assay the alkaloids
will be automatically loaded. This
includes the proper flow of the pumps, run
time, and detector wavelength settings.
8.3.5 Turn on the SDS by pressing the PUMP ON
button at the front panel on the mainframe
of the HPLC. The column will need to
equilibrate for 10 minutes.
8.3.6 You should still be in the FILE
INFORMATION form. Pressing F5
CLC PARAMS: will allow you to verify that
the proper LC settings are loaded (See Form
A6) . The A pump flow should be set to 2.5
mL/min and the run stop time should be
6.0 minutes. Press F8 to exit.
8.3.7 You should still be in FILE INFORMATION
form. Pressing F6 [DAD FARMS] will allow
vou to verify that the detector is set at
the proper settings. The A signal should
be set to 235 nm (See Form A7> .
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FORM A5
FILE INFORMATION
PARAMETER FILE
Param. File Name
Last Change Date 10 Apr 88 2: 10 am
2nformation : 20Z(20mM KH2P04.0.D05M TBA, PH 5.1), 801 ACN, 0.04 V/VZ TEA
Last Altered By : GREGG C. HIDER
DATA FILE
Data File Name DATA.-TEST1.D
Operator Name : STUDENT
~
Sample Name : ALKALOIDS
Further Comments : GETTING READY TO RUN A SAMPLE
Load Parameter File - Enter a File Name or type "?' to list a disc volume
Escape'
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FORM A6
LIQUID CHROMATOGRAPH initial parameters
Flow
Solvent A
B
CI
52 ml /min
10&.0 X
off
off narrow
Max Pressure 400 bar Min Pressure : off
Stop Time
Post Time
6.00 min
0.00 min Contacts : 0000
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FORM A7
DIODE-ARRAY DETECTOR
SIGNALS ABC
off off
Sample (nm)
Wavelength : gg
Bandwidth : 4
Reference (nm)
Wavelength : 550
Bandwidth : 1D0
signals 5: spectra
D E F G H
off off off off off
Store Spectrum : peak controlled about 76 Records acquired during Run
Threshold : 10.0 mftU
Peakwidth : 0.100 min Sampling Interval 540 ms
Stop Time : same as LC Spectrum Range from : 210 nm
to : 400 nm
MONITOR
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8.3.8 Press F8 to exit. You should still be in
the FILE INFORMATION form.
8.3.9 Press F8 [EXIT].
8. 4 Running an Anal vsi s
8.4.1 You should now be in the PREPARE TO
INJECT form. Press the return key several
times until the highlighted area is moved
adjacent to the Data File Name field (See
Form A8) .
8.4.2 Type ALKSTD1.D. Press the return key-
This will create a new file name. This is
the name of your raw data file for your
first standard injection.
8.4.3 Lift the cover on the HPLC exposing the
manual injector port and valve.
8.4.4 Fill a 250 uL Hamilton syringe with
standard level 1 prepared in section 6.1.
8.4.5 Turn the injector valve to the load
position. The handle should be pointed at a
2 o'clock position.
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FORM A8
PREPARE TO INJECT
ta n le Name DflTFhTESTl.D
Flow 2.500 0.000 ml /mm
Solvent A 100.0 0.0 5
B off
CI off
Max Pressure 400 1 bar
Stop Time 6.00 0.00 min
7 May 88 12:57 pm
overwri te
: narrow
Contacts : 0000 0000
LC PRERUN
DAD PRERUN
** Enter a filename of up to 8 characters or
'?'
to list a disc volume **
MONITOR
EDIT
PARFfIS
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8.4.6 Insert the needle all the way into the
injection port. Allow the syringe
barrel to lay on the black rest. Slowly
inject 200 pL of standard, observing
that liquid will drip into the waste
beaker. You have properly overfilled the
100 pL fixed sample loop which will
reduce the chances of carry-over from a
previous injection. Leave the syringe in
this posi t i on .
8.4.7 Carefully, but deliberately, turn the
injection valve to the inject position.
The handle should be pointed at a 4
o'clock position. A contact closure is
made and the run automatically begins and
will stop in 6.0 minutes.
8.4.8 You should still be in the PREPARE TO
INJECT form. You can view the
chromatography in a real time mode by
pressing F3 [MONITOR]. After 6 minutes,
press F8 [EXIT] to return to the PREPARE TO
INJECT form.
8.4.9 Using the return key, move the highlighted
area adjacent to the Data File Name field
(See Form A9) .
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FORM A9
PREPARE TO INJECT
Data Fi le Name : L'ATR:ALKSTD1.D.
Flow 2.5G0 D.000 ml /min
Solvent A 100.0 0.0 X
B off
cT off
7 May 88 1:03 pm
overwri te
narrow
Max Pressure : 400 0 bar
Stop Time : 6.00 0.00 mm
Contacts : 0000 0000
LC PRERUN
DAD PRERUN
** Enter a filename of up to 8 characters or
'?' to list a disc volume **
MONITOR
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8.4.10 :ype ALKSTD2.D. Press the return key.
~his will create a new file name. This is
the name of your raw data file for your
second standard injection.
8.4.11 Remove the syringe from the injection port.
8.4.12 Rinse the syringe well with methanol.
8.4.13 Fill a 250 pL Hamilton syringe with
standard level 2 prepared in section 6.2.
8.4.14 Cnce again, turn the injector valve to the
load position. The handle should be
pointed at a 2 o'clock position.
8.4.15 Dnce again, insert the needle all the way
into the injection port. Allow the syringe
barrel to lay on the black rest. Slowly
inject 200 pL of standard, observing
that liquid will drip into the waste
teaker. Leave the syringe in this
r-osi t i on .
8.4.16 Dnce again, carefully, but deliberately,
turn the injection valve to the inject
position at 4 o'clock. The run
automatically begins and will stop in 6.0
mi nutes.
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8.4.17 You should still be in the PREPARE TO
INJECT form. Remember, vou can view the
chromatography in a real time mode by
pressing F3 [MONITOR]. After 6 minutes,
press F8 [EXIT] to return to the PREPARE TO
INJECT form.
8.4.18 Using the return key. move the highlighted
area adjacent to the Data File Name form
(See Form A10). Type UNKNOWN l.D. Press
the return key. This will create a new
file name. This is the name of your
raw data file for your unknown sample
i n j ecti on .
8.4.19 Remove the syringe from the injection port.
8.4.20 Rinse the syringe well with methanol.
8.4.21 Fill a 250 pL Hamilton syringe with
unknown sample, prepared in section 7.
8.4.22 Inject the sample repeating steps
8. 4. 14 thru 8. 4. 20.
8.4.23 You should still be in the PREPARE TO
INJECT form. Remember, you can
view the chromatography in a real time
mode by hitting F3 CM0NIT0R]. After 6
minutes press F8 [EXIT! to return to the
PREPARE TO INJECT form.
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FORM A10
REPARE TO INJECT
Data File Name DfiTA:ALKSTD2.D. ..
Flow 2.500 0.000 ml /min
SolvenT A 100.0 0.0 X
B off
el off
Max Pressure 400 1 bar
Stop Time 6.00 0.00 min
8 May 83 10:09 pm
overwr i te
: narrow
Contacts : DD00 0000
LC PRERUN
DAD PRERUN
** Enter a filename of up to 8 characters or
'?'
to list a disc volume **
MONITOR PHRAMS
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8.4.24 You are now done with the analysis part of
this laboratory procedure.
8. 5 Calculate the Area Under the Peaks
8.5.1 You should still be in the PREPARE TO
INJECT form. Return to the top level
form by pressing F8 [QUIT].
8.5.2 Press F3 [DATA EDITOR]. This is the area
where you may review your data, acquire
chromatograms, review retention times and
electronically acquire peak area data
(integrate) needed for quantitative work.
8.5.3 The first form you observe will prompt vou
to type a file name. Type ALKSTD1.D and
press return. The computer will display
the chromatogram obtained for that sample.
8.5.4 Go to the next form by pressing F4 CINTEG
KEYS].
8.5.5 Press F3 [Integ.J. The area under each of
your peaks will be electronically
calculated (integrated).
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8.5.6 Press the shift and print keys
simultaneously to get a hard copy of your
integrated chromatogram displayed in this
form.
8.5.7 Press F4 [List Int Results] to obtain your
integrated data.
8.5.8 Press F5 [Send to Printer] to obtain a hard
copy.
8.5.9 Press F8 [Stop Tabulate] to go to the
previous form.
8.5.10 Press FS [EXIT!. This will allow you to go
to a form that will allow you to change
your data file name.
8.5.11 Press Fl [New Data File]. You will again
be prompted to type a file name. Type
ALKSTD2.D and hit return. The computer
will display the chromatogram obtained for
that sample.
8.5.12 Repeat steps 8.5.4 through 8.5.11. You
now have chromatograms and integrated peak
areas for all of your alkaloid standards.
8.5.13 Repeat steps 8.5.4 through 8.5.11 for
the unknown sample. Remember that the file
name is UNKN0WN1.D.
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8.5.14 Press F8 CQUIT]. You are finished with the
data editor. You should now have
chromatograms and integrated peak areas
for the 3 samples injected in section 8.4
(See Figures 7-9).
Instrument Shut-down
9. 1 Flushing Out the System
9.1.1 Turn off the pump by using the on/off
buttons on the panel in the front of the
mainframe LC.
9.1.2 Switch the eluent bottle you have been
using with one containing HPLC-grade water,
9.1.3 Turn the pump on. Flush the system and
column for 10 minutes.
9.1.4 Turn off the pump .
9.1.5 Switch this water bottle with the one
containing 107. v/v methanol prepared in
section 4.5.
9.1.6 Turn the pump on. Flush the system and
column for a minimum of 10 minutes.
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FIGURE 7
Chromatogram and Intergrated Peak Area for Alkaloid
Standard Level 1
[Integll
T: null.
Z: LC A 235,4 550,100
Y: null.
X: null.
LC A 235,4 550 ,100 of A
ALKSTD1 .D
Peak* Ret Tine Type Width
1 1.794 BB 0.0B2
2 2.415 BB 0.081
3 2.958 Bv 0.135
4 3.473 PB 0.145
5 5.054 BB 0.170
Area Start Time End Time
120.13 1 .700 2.019
59.16 2.285 2.BB9
48.98 2.754 3.286
248. Bl 3.28G 3.925
145.91 4.8B2 5.414
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FIGURE 8
Chromatogram and Intergrated Peak Area for Alkaloid
Standard Level 2
LC R 235 . 4 55 D. 1 BB of RLKSTD2 . Q
IBB
MB
120
IBB
BB
BB
4B
20-1
[Integll
m
cn
G
X^
Tl me C m 1 n . 3
T: LC A 235,4 550, 100
Z: LC A 235,4 550, 100
Y: null.
X: null.
LC A 235,4 550 ,100 of A
ALKSTD2.D
Peak* Ret Time Type Width
1 1.794 BV 0.0E6
2 2.41S BB 0.08G
3 2.955 BU 0.118
4 3.443 \)B 0.152
5 5.095 BB 0.154
LKSTD2.D
Area St ar t Time End Time
689.07 1.624 1 .944
325.70 2.285 2.657
321 .48 2.806 3.243
1G36 3.243 4.318
146.76 4.925 5.458
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FIGURE 9
Chromatogram and Intergrated Peak Area for Unknown
Sample Mix of Alkaloids
BB-]
7B
EB-
5B
4B
30
2B
IB
LC R 235.4 55B. 1 00 of UNKNOWN 1 . D
01
IS
A.
[Inteql]
LC A 235,4
550,'
UNKN0WN1 .D
T: LC A 235,4 550,100
Z: LC A 235,4 550,100
Y: null.
X: null.
of UNKN0WN1 .D
Peak* Re t Time Type Width Area Start Time Erid Time
1 1 .798 BB 0.064 326.39 1 .692 1 .935
2 2.421 BH 0.083 149.06 2.309 2.588
3 2.965 Bv 0.1 18 152.56 2.799 3.254
4 3.467 PB 0.149 758.16 3.254 4.162
5 5.090 Bv 0.161 141 .51 4.939 5.493
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9. 2 Shutting Down the System
9.2.1 Turn all the electrical components off in
exactly the reverse order that you turned
them on.
9.2.2 Be sure that the switch on the 6 outlet
power strip has been turned off.
10. Cal cul ati ons
10. 1 Component Identification
Elution Order Compound Retention Time (min)
1 Cocaine 1.79
2 Codeine 2.42
3 Hydromorphone 2.96
4 Qui nine 3. 46
5 Strychnine 5.09
10.2 Peak Area Ratio (PAR). A separate peak area ratio
must be calculated for every compound in every
i n j ect i on .
Aix
PARix =
Ais
Where PARix = The peak area ratio for a
compound (x) within a sample
i n jecti on ( i ) .
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Where Aix = The peak area of a compound
(x) within a sample injection
(i ) .
Where Ais = The peak area of the
internal standard (s) within
a sample injection (i).
10.3 Response Factor (Rf). A separate response factor
must be calculated for every compound.
Cix
Rfix =
PARix
Where Rfix = Response factor for a compound (x>
in standard (i) level 1 or 2.
Where Cix = Concentration (pg/mL) of a
compound (x) in standard (i) level 1 or
2 prepared in section 6.1 or 6.2.
10.4 Average Response Factor (RF) of Standard Level 1
and 2
Cix C2x
PARix PAR2x
RFx = =
Where RFx = The average response factor of
standard level 1 and 2 of a compound
(x ) .
Where Cix = The Concentration (pg/mL) of a
compound (x) in standard level 1.
Where C2x = The Concentration (pg/mL) of a
' compound (x) in standard level 2.
Where PARix = The peak area ratio of a compound
(x) in standard level 1.
Where PAR2x = The peak area ratio of a compound
(x) in standard level 2.
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10.5 Calculate the Concentration of a Compound in the
Unknown Sample
Cux = (RFx) (PARux)
Where Cux = The unknown concentration of a
compound (x) within the unknown sample
mix (u> prepared in section 7.
11- Sample Calculations (Data collected from Figures 7-9)
Peak #1 Compound Aix A2x Aux
1 Cocaine 120 689 326
5 Strychnine 146 147 142
11.1 Calculation of the Peak Area Ratios
Aix
PARix =
Ais
11.1.1 PAR for cocaine standard level 1
120
= = 0.822
146
11.1.2 PAR for cocaine standard level 2
689
= = 4.687
147
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11.2 Calculation of the Response Factors (Rf)
Ci x
Rfix =
PARix
11.2.1 Response factor for cocaine standard
level 1
2.0 pg/mL
= = 2.433
0.822
11.2.2 Response factor for cocaine standard
level 2
10.0 pg/mL
= = 2.134
4.687
11.3 Calculation of the Average Response Factor (RFx)
Rfix + Rf2x
RFx =
2
11.3.1 Calculation of the RFx for Cocaine
2. 433 + 2. 134
= 2.284
11.4 Calculation of the Cocaine Concentration in the
Unknown Sample
326
PARix = = 2.30
142
(RFx) (PARix) = (2.284) (2.30) = 5.25 pg/mL
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B. Simultaneous Hi gh-Perf ormance Liquid Chromatographic
Analysis of Analgesics
1 . Introduct i on
1.1 The analgesics investigated in this procedure
are organic acids or derivatives of an organic
acids with simple cyclic structures. All contain
the familiar benzene ring. Acetyl sal i cyl i c acid,
salicylic acid, acetami nophenol , caffeine, and
phenacetin are the compounds included in this
investigation. Acetyl sal i cyl i c acid (aspirin) and
acetaminophen are two of the most widely used
over-the-counter pain relievers sold in the
United States. Millions of pounds of these
compounds are sold annually- In addition to being
good pain relievers both are antipyretic drugs
(fever reducers). Only aspirin is an effective
anti -i nf lammatory agent. Salicylic acid was
included in this study, since ingested
acetyl sal icyl ic acid is absorbed and rapidly
hydrolyzed into salicylic acid. Caffeine was also
included in this investigation even though it is
Bl
neither an organic acid nor an analgesic. However,
it is often included in over-the-counter
preparations of analgesics. Phenacetin is an
analgesic but is no longer used due to concern
about its toxicity. Thus this compound was
included as an appropriate internal standard due to
it homology with the other analgesics studied.
2. Purpose
2.1 HPLC is a valuable analytical tool available for
the determination of blood and plasma levels of
analgesics. The purpose of this laboratory
procedure is to familiarize the clinical chemistry
student with the basic operation of a semi-
automated high-performance liquid chromatograph so
that he can gain experience with this separation
technique and learn some practical analytical
skil Is.
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3. Summary of Method
3.1 Acetyl sal i cvl i c acid, salicylic acid,
acetami nophenol . caffeine, and phenacetin are
dissolved in eluent and chromatographed on an
Alltech C8 bonded phase cartridge column. The HPLC
separation is done i socrati cal 1 y (a single eluent
system), in the reverse-phase mode using an ion
suppression technique. Mixtures of the drugs are
differentially partitioned on this column and
clearly resolved. Spectrophotometri c detection is
performed at 254 nm. Quantitation is done by
mathematically comparing detector response of drug
standards to unknowns. Pheqacetin, the internal
standard, is added to each sample at a constant
level so that small variations in technique, such
as injection, can be corrected.
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Materials and Reagents
4. 1 Apparatus
4.1.1 A Hewlett-Packard high-performance liquid
chromatographic system was used for all
analytical work (Hewlett Packard.
Avondale, PA 19311-0900). The major
components housed within the mainframe of
this HP 1090 Series M liquid chromatograph
are an HP 1040M photodiode array detector, a
PV5 ternary solvent delivery system, and a
Rheodyne model 7010 manual injection valve.
This system is controlled and monitored by
an HP 79994A Analytical Chemstation. The
central part of this Chemstation is the HP
9000 Series 300 computer. Other important
components included an HP 9153B 20 megabyte
Winchester disc drive with a separate disc
drive for 3.5 inch flexible discs, an HP
35741A color video monitor, keyboard, and an
HP 2225A Thinkjet printer. HP 79995A,
revision 3.11 operating software is also used,
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4.1.2 An Alltech Econosphere C8, 5 um 150 mm
X 4.6 mm i.d. analytical cartridge column was
used (Alltech Associates, Inc., Deer-field,
IL 60015., C/N. 71012).
4.1.3 An Alltech C8 guard cartridge column
was also used to protect the analytical
column (Alltech Associates, Inc., C/N. 28017)
4.1.4 Ranin model P-100 and P-1000 digital
pipettes were used. (Ranin Instrument
Company Inc., Woburn, MA 01801).
4.2 Stock Reagents (All reagents are available from the
stockroom)
4.2.1 HPLC-grade water.
4.2.2 HPLC-grade methanol (ME0H).
4.2.3 HPLC-grade isopropyl alcohol (IPA).
4.2.4 Reagent grade glacial acetic acid (H0AC).
4.2.5 Acetyl sal i cyl ic Acid (Sigma Chemical
Company. St. Louis, Mo 63178. Sigma No.
A-5376) .
4.2.6 Salicylic Acid (Sigma Chemical Company.
Sigma No. S-0875) .
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4.2.7 4-Acetami dophenol (Sigma Chemical Company.
Sigma No. A-5000).
4.2.8 Caffeine (Sigma Chemical Company. Sigma No.
C-0750) .
4.2.9 Acetophenetidin (Sigma Chemical Company.
Sigma No. A-2375) .
4.3 Stock 1.07. HOAC (ID
4.3.1 Add 1 mL of HOAC into a IL volumetric flask.
4.3.2 Add HPLC-grade water to the mark.
4.3.3 Mix by inversion.
4.4 Eluent (ID 387. MEOH
627. Water containing 17. HOAC
4.4.1 In a IL graduated cylinder, add 380 mL of
HPLC-grade MEOH.
4.4.2 Add 620 mL of the stock 1.07. HOAC prepared
secti on 4.3.
4.4.3 Mix well, place in a IL HP solvent reservoir
bottle and degas under vacuum in a sonic-
bath for 1 minute.
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4.5 Column Storage Solution (ID 107. v/v MEOH
4.5.1 In a IL graduated cylinder, add 100 mL of
HPLC-grade MEOH.
4.5.2 Add HPLC-grade water up to the IL mark.
4.5.3 Mix well, place in a IL HP solvent reservoir
bottle and degas under vacuum in a sonic-
bath for 1 minute.
5. Stock Standards
5.1. Acetyl sal i cyl i c Acid (Aspirin) Standard. 1.0 mg/mL
(25 mL)
5.1.1 Weigh 25.0 mg of acetyl sal i cyl i c acid into a
25 mL class A volumetric flask.
5.1.2 Add eluent (prepared in section 4.4) to the
mark and dissolve completely.
5. 2 Salicylic Acid Standard. 1.0 mg/mL (25 mL)
5.2.1 Weigh 25.0 mg of salicylic acid
into a 25 mL class A volumetric flask.
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5.2.2 Add eluent (prepared in section 4.4) to the
mark and dissolve completely.
5. 3 Acetami dophenol (Acetaminophen) Standard. 1.0 mg/mL
(25 mL)
5.3. 1 Weigh 25.0 mg of acetaminophen into a 25 mL
class A volumetric flask.
5.3.2 Add eluent (prepared in section 4.4) to the
mark and dissolve completely.
5. 4 Caffeine Standard. 1.0 mg/mL (25 mL)
5.4.1 Weigh 25.0 mg of caffeine into a 25 mL class A
volumetric flask.
5.4.2 Add eluent (prepared in section 4.4) to the
mark and dissolve completely.
5. 5 Acetophenetidin (Phenacetin) Internal Standard, 1.0
mg/mL (25 mL)
5.5.1 Weigh 25.0 mg of phenacetin into a 25 mL cla;
A volumetric flask.
5.5.2 Add eluent (prepared in section 4.4) to the
mark and dissolve completely.
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6. Preparation of Working Analgesic Standards for
Calibration (10 mL)
6. 1 Level 1 Acetaminophen at 10.0 ug/mL
Caffeine at 5.0 pg/mL
Aspirin and Salicylic Acid at 50.0 pg/mL
Phenacetin at 15.0 ug/mL
6.1.1 Add the following volumes of the appropriate
1.0 mg/mL stock standard to a 10 mL class A
volumetric flask using an appropriate pipette.
Acetaminophen - 100 pL
Caffeine - 50 pL
Aspirin and Salicylic Acid - 500 pL
Phenacetin - 75 pL
6.1.2 Add eluent (prepared in section 4.4) to the
10 mL mark. Mix by inversion.
6.2 Level 2: Acetaminophen at 30.0 pg/mL
Caffeine at 20.0 pg/mL
Aspirin and Salicylic Acid at 200.0 pg/mL
Phenacetin at 15.0 pg/mL
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6.2.1 Add the following volumes of the appropriate
1.0 mg/mL stock standard to a 10 mL class A
volumetric flask using an appropriate pipette.
Acetaminophen - 300 pL
Caffeine - 200 pL
Aspirin and Salicylic Acid - 2.0 mL
Phenacetin - 75 pL
6.2.2 Add eluent (prepared in section 4.4) to the
10 mL mark. Mix by inversion.
7. Preparation of an "Unknown" Sample for Analysis
7.1 Add the following volumes of the appropriate
1.0 mg/mL stock standard to a 10 mL class A
volumetric flask using an appropriate pipette.
7.2
Acetaminophen - 200 pL
Caffeine - 100 pL
Aspirin and Salicylic Acid - 1.0 mL
Phenacetin - 75 pL
Add eluent (prepared in section 4. 4) to the
10 mL mark. Mix by inversion.
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8. Anal ysi s
8. 1 Equipment Set-up
8.1.1 HP1090M and Workstation should be correctly
installed, configured, and operational. If
the system is not operational, refer to the
appropriate operators' manuals (42-45).
8.1.2 The solvent delivery system (SDS) should
already have been primed. If the solvent
system is not operational, refer to the
appropriate sections in the operator's
manual (46). This is usually done by pumping
degassed IPA through each solvent line at
5.0 mL/min for 3-5 minutes.
8.1.3 Load the degassed eluent prepared earlier
into the solvent compartment section
farthest to the left (pump A).
8.1.4 Install the appropriate guard cartridge and
analytical cartridge column.
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8. 2 Instrument Start-up
8.2.1 Turn on the electrical power to the
analytical workstation by switching on the
tan 6 outlet power strip located along the
wall behind the computer.
8.2.2 Turn on the electrical power to the
mainframe HPLC by pressing the POWER-ON
button located on the front panel in the
lower right corner.
8.2.3 Turn on the diode array detector (DAD) by
pressing the DETECTOR-ON button located
on the same panel. The deuterium lamp
requires 15-30 minutes warm-up time.
8.2.4 Turn on the Think Jet Printer. (The switch
is located in the back right corner).
8.2.5 Turn on the 20 MB hard drive (9153B) bv
depressing the rectangular button located in
front on the left side.
8.2.6 Turn on the CRT by depressing the
rectangular button located in front on the
lower left side.
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8.2.7 Turn on the computer by depressing the
rectangular button located in the front cn
the lower left side. Several screens
should automatically be displayed on the CRT
screen, indicating that memory is being
loaded, tested, and that the system is
booted .
8.2.8 The system should now be fully operational.
All operations and commands can now be
controlled from the keyboard. Please note
the keys labeled fl-fB across the top of
the keyboard. They are essential to the
operation of this system and will be used
frequently to initiate operations described
in the green boxes viewed across the
bottom of the CRT screen. Each screen
viewed is called a form, which contains
several functions that can be initiated
through commands from the keyboard.
8.2.9 Verify the correct date on the bottom of
the CRT screen. Proceed by pressing the
return key on the keyboard.
8.2.10 Verify the correct time. Proceed by
pressing the return key on the keyboard.
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8.3 Getting Ready to Run an Analysis - You are now in
the CTop Level 1 of a hierarchial tree of
functions (See Form Bl).
8.3.1 Press F2, [Data Acquisition] to load the
data acquisition program.
8.3.2 The next screen (form) is the PREPARE TO
INJECT form (See Form B2) . Press F6, [EDIT
PARAMS].
8.3.3 You are now in the FILE INFORMATION form.
If the analgesic parameter file is not
loaded (See Form B3> , press Fl [Load
ParamsJ. You will be prompted to type
the name of a parameter file (See Form B4>.
8.3.4 Type DATA: GESICS. A over the previously
loaded parameter file name. (See Form B5) .
Press return. All the proper operating
parameters needed to assay the analgesics
will be automatically loaded. This
includes the proper flow of the pumps, run
time, and detector wavelength settings.
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FORM Bl
HP 7 9 9 9 4 A
HPLC WORKSTATION
for HP 104OM
and HP 1090M
Copyright 1985, Hewlett-Packard Company
[TOP LEVEL]
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FORM B2
PREPARE TO INJECT
Data File Name : DATA:TEST1.D
Flow IMBgg 0.000 ml /min
SolvenT A 100.0 0.0 X
B 0.0 0.0 X
ci 0.0 0.0 X
7 May 88 12:31 pm
overwri te
: narrow
Max Pressure : 400 0 bar
Stop Time : no limit 0.00 min
Contacts : 0000 0000
LC PRERUN
DA0 PRERUN
MONITOR
Stop:_ EDIT,
Run^l PARAMS:
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FORM B3
FILE INFORMATION
PARAMETER FILE
Param. File Name DATA:TEST.A
Last Change Date 10 Apr 88 2:10 am
information :
Last Altered By :
DATA FILE
Data File Name DATA: TEST l.D
Operator Name :
Sample Name :
Further Comments :
PARRMS PftRRMS
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FORM B4
FILE INFORMATION
PARAMETER FILE
Param. File Name
Last Change Date 10 Apr 38 2: 10 am
2nformation :
Last~Altered By :
DATA FILE
Data File Name DATA:TEST1.D
Operator Name :
Sample Name :
Further Comments :
Load Parameter File - Enter a File Name or type '?' to list a disc volume
Escape
BIS
FORM B5
FILE INFORMATION
PARAMETER FILE
Param. File Name DATA-.GES1CS.A
Last Change Date 10 Apr 88 2:17 am
information : 62X HATER (IX ) PH 2.8, 3GX MEOH 1.0 ML/MI N. 254 NM C8 lOOuL
Last Altered By : GREGG C. HIDER
DATA FILE
Data File Name TEST1.D
Operator Name : STUDENT
Sample Name :
Further Comments : GETTING READY TO RON A SAMPLE
ANALGESIC. DRUGS-
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8.3.5 Turn on the SDS bv pressing the PUMP ON
button at the front panel on the mainframe
of the HPLC. The column will need to
equilibrate for 10 minutes.
8.3.6 You should still be in the form titled
FILE INFORMATION. Pressing F5 LLC PARAMS]
will allow you to verify that the proper LC
settings are loaded (See Form B6). The "A"
pump flow should be set to 1.0 mL/min and
the run stop time should read 7-5 minutes.
Press F8 to exit.
8.3.7 You should still be in the form titled
"FILE INFORMATION". Pressing F6 [DAD
PARMS] will allow you to verify that the
detector is set at the proper settings.
The "A" signal should be set to 254 nm (See
Form B7) .
8.3.8 Press F8 to exit. You should still be in
the form titled "FILE INFORMATION".
8.3.9 Press F8 [EXIT].
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FORM B6
LIQUID CHROMATOGRAPH initial parameters
Flow
SolvenT A
B
Ci
ml /min
100.0 X
off
off : narrow
Max Pressure
Stop Time
Post Time
400 bar
7.50 min
0.00 min
Mm Pressure : off
Contacts : 0000
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FORM B7
DIODE-ARRAY DETECTOR signals & spectra
SIGNALS ABCDEFGH
Sample (nm)
Wavelength : 254 off off gj off off off off
Bandwidth : 4
Reference (nm)
Wavelength : 550
Bandwidth : 100
Store Spectrum : peak controlled about 92 Records acquired during Run
Threshold : 10.0 mAU
Peakwidth : 0. 10& mm
Stop Time : same as LC
Sampling Interval 40 ms
Spectrum Range from : 210 nm
~
to : 400 nm
** Press <on> or <off> to set Siqnal **
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8. 4 Running an Analysis
8.4.1 You should now be in the PREPARE TO INJECT
form. Press the return key several times
until the highlighted area is moved
adjacent to the Data File Name field (See
Form B8) .
8.4.2 Type ANASTD1.D. Press the return key.
This will create a new file name. This is
the name of your raw data file for your
first standard injection.
8.4.3 Lift the cover on the HPLC exposing the
manual injector port and valve.
8.4.4 Fill a 250 pL Hamilton syringe with
standard level 1 prepared in section 6.1.
8.4.5 Turn the injector valve to the load
position. The handle should be pointed at a
2 o'clock position.
8.4.6 Insert the needle all the way into the
injection port. Allow the syringe
barrel to lay on the black rest. Slowly
inject 200 pL of standard, observing
that liquidxwill drip into the waste
beaker. You have properly overfilled the
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FORM B8
PREPARE TO INJECT
ta File Name ['ATA:TEST1.D
Flow 2.500 0.000 ml/min
Solvent A 100.0 0.0 X
B off
Ci off
Max Pressure 400 1 bar
Stop Time 6.00 0.00 min
7 May 88 12:57 pm
overwri te
narrow
Contacts : 0000 0000
LC PRERUN
DA0 PRERUN
** Enter a filename of up to 8 characters or
'?'
to list a disc volume **
ED1T\
PARfiMS
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100 uL fixed sample loop whicn will
reduce the chances of carry-over from a
previous injection. Leave the syringe in
this position.
8.4.7 Carefully, but deliberately, turn the
injection valve to the inject position.
The handle should be pointed at a 4
o'clock position. A contact closure is
made and the run automatically begins and
will stop in 7.5 minutes.
8.4.8 You should still be in the PREPARE TO
INJECT form. You can view the
chromatography in a real time mode by
pressing F3 [MONITOR]. After 7.5 minutes,
press F8 [EXITT to return to the PREPARE TO
INJECT form.
8.4.9 Using the return key, move the highlighted
area adjacent to the Data File Name field
(See Form B9) .
8.4.10 Type ANASTD2.D. Press the return key.
This will create a new file name. This is
the name of your raw data file for your
second standard injection.
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FORM A9
PREPARE TO INJECT
Data File Name
Flow
Solvent A
B
Ci
HNfiSTDl.D
1.000 0.000 ml /min
100.0 0.0 X
off
off
7 May 88 5:36 pm
overwr i te
narrow
Max Pressure : 400 0 bar
Stop Time : 7.50 0.00 min
Contacts 0000 0000
LC PRERUN
DAD PRERUN
** Enter a filename of up to 8 characters or
"?' to list a disc volume **
CT35I
MONITOR
.
ED1T-
PARAMS
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8.4.11 Remove the syringe from the injection port.
8.4.12 Rinse the syringe well with methanol.
8.4.13 Fill a 250 pL Hamilton syringe with
standard level 2 prepared in section 6.2.
8.4.14 Once again, turn the injector valve to the
load position. The handle should be
pointed at a 2 o'clock position.
8.4.15 Once again, insert the needle all the wav
into the injection port. Allow the syringe
barrel to lay on the black rest. Slowly
inject 200 pL of standard observing that
liquid will drip into the waste beaker.
Leave the syringe in this position.
8.4.16 Once again, carefully, but deliberately
turn the injection valve to the inject
position at 4 o'clock. The run
automatically begins and will stop in 7.5
mi nutes.
8.4.17 You should still be in the PREPARE TO
INJECT form. Remember, you can view the
chromatography in a real time mode by
pressing F3 [MONITOR]. After 7.5 minutes,
press F8 [EXIT] to return to the PREPARE TO
INJECT form.
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8.4.18 Using the return key, move the highlighted
area adjacent to the Data File Name form
(See Form BIO). Type UNKN0WN2.D. Press
the return key. This will create a new
file name. This is the name of your
raw data file for your unknown sample
i n j ecti on .
8.4.19 Remove the syringe from the injection port.
8.4.20 Rinse the syringe well with methanol.
8.4.21 Fill a 250 pL Hamilton syringe with
unknown sample, prepared in section 7.
8.4.22 Inject the sample repeating steps
8. 4. 14 thru 8. 4. 20.
8.4.23 You should still be in the PREPARE TO
INJECT form. Remember, you can view the
chromatography in a real time mode by
hitting F3 [MONITOR]. After 7.5 minutes
press FB [EXIT] to return to the PREPARE TO
INJECT form.
B28
FORM BIO
PREPARE TO INJECT
Data File Name :
Flow
SolvenT A
B
Ci
ANASTD2.D
1.000 0.000 ml /min
100.0 0.0 X
off
off
7 May 88 5:37 pm
overwri te
: narrow
Max Pressure : 400 3 bar
Stop Time : 7.50 0.00 min
Contacts : 0000 0000
LC PRERUN
DAD PRERUN
** Enter a filename of up to 8 characters or
"<" to list a disc volume **
I StartRun-^ ED1T;PARAMS
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8.4.24 You are now done with the analysis part of
this laboratory procedure.
8. 5 Calculate the Area Under the Peaks
8.5.1 You should still be in the PREPARE TO
INJECT form. Return to the top level
form by pressing F8 [QUIT].
8.5.2 Press F3 [DATA EDITOR]. This is the area
where you may review your data, acquire
chromatograms, review retention times and
electronically acquire peak area data
(integrate) needed for quantitative work.
8.5.3 The first form you observe will prompt you
to type a file name. Type ANASTD1.D and
press return. The computer will display
the chromatogram obtained for that sample.
8.5.4 Go to the next form by pressing F4 CINTEG
KEYS].
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8.5.5 Press F3 Clnteg.]. The area under each of
your peaks will be electronically
calculated (integrated).
8.5.6 Press the shift and print keys
simultaneously to get a hard copy of your
integrated chromatogram displayed in this
form.
8.5.7 Press F4 [List Int Results] to obtain your
integrated data.
8.5.8 Press F5 [Send to Printer] to obtain a hard
copy.
8.5.9 Press F8 [Stop Tabulate] to go to the
previous form.
8.5.10 Press F8 [EXIT]. This will allow you to go
to a form that will allow you to change
your data file name.
8.5.11 Press Fl [New Data File]. You will again
be prompted to type a file name. Type
ANASTD2.D and hit return. The computer
will display the chromatogram obtained for
that sample.
8.5.12 Repeat steps 8.5.4 through 8.5.11. You
now have chromatograms and integrated peak
areas for all of your anagesic standards.
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8.5.13 Repeat steps 8.5.4 through 8.5.11 for
the unknown sample. Remember that the file
name is UNKN0WN2.D.
8.5.14 Press F8 [QUIT]. You are finished with the
data editor. You should now have
chromatograms and integrated peak areas
for the 3 samples injected in section 8.4
(See Figures 10-12).
Instrument Shut-down
9. 1 Flushing Out the System
9.1.1 Turn off the pump by using the on/off
buttons on the panel in the front of the
mainframe LC.
9.1.2 Switch the eluent bottle you have been
using with one containing HPLC-grade water.
9.1.3 Turn the pump on. Flush the system and
column for 10 minutes.
9.1.4 Turn off the pump .
9-1.5 Switch this water bottle with the one
containing 107. v/v methanol prepared in
section 4.5.
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9.1.6 Turn the pump on. Flush the system and
column for a minimum of 10 minutes.
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FIGURE 10
Chromatogram and Intergrated Peak Area for Analgesic
Standard Level 1
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of RNRSTD1 D
as
^
T I ine
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C m 1 n .
dntectl]
LC B 254,4
ANASTD1 .D
550,100
T: LC A 245,4
Z: LC B 254,4
Y: null.
X: null.
550, 100
550, 100
of ANASTD1 .D
Peak*
1
2
3
4
5
Ret Time
2.380
3.
4.
5.
6.
,424
,627
.644
128
Type
BB
BB
BB
BU
UB
Width
0.111
0.128
0. 149
0.192
0.179
Area Star t Time Erid Time
2352 2. 186 2.761
387.53 3.187 3.762
807.45 4.348 5.040
808.62 5.328 5.907
1804 5.907 5.649
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FIGURE 11
Chromatogram and Intergrated Peak Area for Analgesic
Standard Level 2
[Jnteqll
LC 8 254.4 55 0. 1 BB Of RNRSTQ2 D
9BB-
; c
1
BQB-
1
7BB-;
EQQ-
sbb:
m
O 1 IB
4BB:
3BQ-"
2QQ-
1BB-
cn
iJ v. i \i V i j\
2 4 B
Tl me (uln. 3
T: LC A 245,4 550,100
Z: LC B 254,4 550,100
Y: null.
X: null.
LC B 254 ,4 550. 100 of ANAST[)2.D
ANASTD2. D
Peakt R at Time Type Width Area St art Time End Time
1 2.383 Bv 0.1 18 7481 2.175 2.889
2 3.416 BB 0.134 1735 3.208 3.890
3 4.619 BB 0.157 3402 4.358 5.157
4 5.732 Bv 0.250 3422 5.328 5.950
5 6.131 vB 0. 188 1986 5.950 6.734
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FIGURE 12
Chromatogram and Intergrated Peak Area for Unknown
Sample Mix of Analgesics
LC B 254,4 55B, 1 BB of UNKN0NN2.0
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3 3Q0
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T: LC A 245,4 550.100
Z: LC B 254,4 550,100
Y: null.
X: null.
LC B 254,4 550, 100 of U
UNKN0UN2.D
Peakf Ret Time Type Width
1 2.381 BB 0.115
2 3.421 BB 0. 130
3 4.627 BB 0.152
4 5.688 Bv 0.204
5 6.135 vB 0.183
NKN0WN2.D
Area St ar t Time Erid Time
4970 2.199 2.870
824.92 3.232 3.818
1663 4.361 5.08G
1668 5.352 5.932
1893 5.932 6.683
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9. 2 Shutting Down the Svst em
9.2.1 Turn all the electrical components off in
exactly the reverse order that vou turned
them on.
9.2.2 Be sure that the switch on the 6 outlet
power strip has been turned off.
10. Cal cul ati on;
10. 1 Component Identification
Elution Order Compound
1
2
3
4
5
Acetami nophen
Caf f ei ne
Aspi r i n
Sal i cyl i c Aci d
Phenaceti n
Retention Time (min)
2.38
3.42
4.62
5. 68
6. 13
10.2 Peak Area Ratio (PAR). A separate peak area ratio
must be calculated for every compound in every
i n j ecti on .
PARix =
Aix
Ais
Where PARix The peak area ratio for a
compound (x) within a sample
i n jecti on ( i ) .
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Where Aix = The peak area of a compound
(x) within a sample injection
(i ) .
Where Ais = The peak area of the
internal standard (s) within
a sample injection (i).
10.3 Response Factor (Rf). A separate response factor-
must be calculated for every compound.
Ci x
Rfix =
PARix
Where Rfix = Response factor for a compound (x>
in standard (i) level 1 or 2.
Where Cix = Concentration (pg/mL) of a
compound (x) in standard (i) level 1 or
2 prepared in section 6.1 or 6.2.
10.4 Average Response Factor (RF) of Standard Level 1
and 2
Cix C2x
PARix PAR2x
RFx =
Where RFx = The average response factor of
standard level 1 and 2 of a compound
(x > .
Where Cix = The Concentration (pg/mL) of a
compound (x> in standard level 1.
Where C2x = The Concentration (pg/mL) of a
compound (x) in standard level 2.
Where PARix = The peak area ratio of a compound
(x) in standard level 1.
Where PAR2x = The peak area ratio of a compound
(x) in standard level 2.
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10.5 Calculate the Concentration of a Compound in the
Unknown Sample
Cux = (RFx) (PARux)
Where Cux = The unknown concentration of a
compound (x> within the unknown sample
mix (u) prepared in section 7.
11. Sample Calculations (Data collected from Figures 10-12)
Peak #1 Compound Aix A2x Aux
1 Acetaminophen 2352 7481 4970
5 Phenacetin 1804 1986 1893
11.1 Calculation of the Peak Area Ratios
Aix
PARix =
Ais
11.1.1 PAR for acetaminophen standard level 1
2352
= = 1.304
1804
11.1.2 PAR for acetaminophen standard level 2
7481
= = 3.767
1986
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11.2 Calculation of the Response Factors (Rf)
Cix
Rfix =
PARix
11.2.1 Response factor for acetaminophen standard
level 1
10.0 pg/mL
= = 7.669
1.304
11.2.2 Response factor for acetaminophen standard
level 2
30.0 pg/mL
= = 7.964
3.767
11.3 Calculation of the Average Response Factor (RFx)
Rfix + Rf2x
RFx =
2
11.3.1 Calculation of the RFx for acetaminophen
7.669 + 7-964
= 7.816
11.4 Calculation of the Acetaminophen Concentration in
the Unknown Sample
4970
PARix = = 2.63
1893
(RFx) (PARix) = (7.816) (2.63) = 20.6 pg/mL
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C. Simultaneous Hi gh-Perf ormance Liouid Chromatographic
Analysis of Anticonvulsants
1 . Introduct i on
1.1 Many of the compounds investigated in this
procedure are chemically heterogeneous. They
are grouped together because of their similarities
in action. All the compounds included in this
procedure are anticonvulsant drugs which are used
to control seizure disorders. The most commonly
used anticonvulsants are phenobarbi tal and
phenytoin. Other commonly used anticonvulsants
which were included in this study are primidone,
carbamazepine, and ethosuximide.
2. Purpose
2.1 HPLC is a valuable analytical tool available for
the determination of blood and plasma levels of
anticonvulsant drugs. The purpose of this
laboratory procedure is to familiarize the
CI
clinical chemistry student with the basic operation
of a semi -automated high-performance liguid
chromatograph so that he can gain experience with
this separation technique and learn some
practical analytical skills.
3. Summary of Method
3.1 Ethosuximide, primidone, phenobarbi tal ,
di phenyl hydantoi n , carbamazepine, and hexobarbital
are dissolved in eluent and chromatographed on an
Alltech C8 bonded phase cartridge column. The HPLC
separation is done i socrati cal 1 y (a single eluent
system), in the reverse-phase mode. Mixtures of
the drugs are differentially partitioned on this
column and clearly resolved. Soectrophotometr i c
detection is performed at 210 nm. Quantitation
is done by mathematically comparing detector
response of drug standards to unknowns.
Hexobarbital, the internal standard, is added to
each sample at a constant level so that small
variations in technique, such as injection, can be
corrected .
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Materials and Reagents
4 . 1 Apparatus
4.1.1 A Hewlett-Packard high-performance liquid
chromatographic system was used for all
analytical work (Hewlett Packard,
Avondale, PA 19311-0900). The major
components housed within the mainframe of
this HP 1090 Series M liquid chromatograph
are an HP 1040M photodiode array detector, a
PV5 ternary solvent delivery system, and a
Rheodyne model 7010 manual injection valve.
This system is controlled and monitored by
an HP 79994A Analytical Chemstation. The
central part of this Chemstation is the HP
9000 Series 300 computer. Other important
components included an HP 9153B 20 megabyte
Winchester disc drive with a separate disc
drive for 3.5 inch flexible discs, an HP
35741A color video monitor, keyboard, and an
HP 2225A Thinkjet printer. HP 79995A,
revision 3.11 operating software is also
used.
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4.1.2 An Alltech Econosphere C8, 5 pm 150 mm
X 4.6 mm i.d. analytical cartridge column was
used (Alltech Associates, Inc., Deerfield,
IL 60015.. C/N. 35818).
4.1.3 An Alltech C8 guard cartridge column
was used to protect the analytical
column (Alltech Associates, Inc., C/N. 28017)
4.1.4 Ranin model P-100 and P-1000 digital
pipettes were used. (Ranin Instrument
Company Inc., Woburn, MA 01801).
4.2 Stock Reagents (All reagents are available from the
stockroom)
4.2.1 HPLC-grade water.
4.2.2 HPLC-grade methanol (MEOH).
4.2.3 HPLC-grade acetonitrile (ACN).
4.2.4 HPLC-grade isopropyl alcohol (IPA).
4.2.5 Reagent grade monobasic potassium phosphate
(KH2P04) .
4.2.6 Ethosuximide (Alltech Associates, Inc.,
Stock No. 01845) .
4.2.7 Primidone (Alltech Associates, Inc.,
Stock No. 01781) .
4.2.8 Phenobarbi tal (Sigma Chemical Company.
St. Louis, Mo. 63178. Sigma No. P-1636) .
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4.2.9 Hexooarbital (Sigma Chemical Company. Sigma
No. H-1005) .
4.2.10 5, 5-Di phenyl hydantoin (Sigma Chemical Company.
Sigma No. D-4007) .
4.3 Stock 0. 1 M Potassium Phosphate Buffer (ID
4.3.1 Add 13.61 g of KH2P04 into a IL graduated
cvl i nder .
4.3.2 Add HPLC-grade water to IL mark.
4.3.3 Stir until completely dissolved.
4.4 Eluent (ID 547. Buffer (0.1 M KH2P04 )
467. MEOH
4.4.1 In a IL graduated cylinder, add 540 mL of the
0.1 M stock buffer prepared in section 4.3.
4.4.2 Add 460 mL of HPLC-grade MEOH.
4.4.3 Mix well, place in a IL HP solvent reservoir
bottle and degas under vacuum in a sonic-
bath for 1 minute.
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4.5 Column Storage Solution (ID 107. v/v MEOH
4.5.1 In a IL graduated cylinder, add 100 mL of
HPLC-grade MEOH.
4.5.2 Add HPLC-grade water up to the IL mark.
4.5.3 Mix well, place in a IL HP solvent reservoir
bottle and degas under vacuum in a sonic-
bath for 1 minute.
5. Stock Standards
5.1. Ethosuximide Standard. 1.0 mg/mL (25 mL)
5.1.1 Weigh 25.0 mg of ethosuximide into a 25 mL
class A volumetric flask.
5.1.2 Add MEOH to the mark and dissolve
compl etel y .
5. 2 Primidone Standard, 1.0 mg/mL (25 mL)
5.2.1 Weigh 25.0 mg of primidone into a 25 mL class
A volumetric flask.
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5.2.2 Add MEOH to the mark and dissolve
compl etel y .
5. 3 Phenobarbi tal Standard. 1.0 mg/mL (25 mL)
5.3.1 Weigh 25.0 mg of phenobarbi tal into a 25 mL
class A volumetric flask.
5.3.2 Add MEOH to the mark and dissolve
compl etel y .
5. 4 Di phenyl hydantoin Standard. 1.0 mg/mL (25 mL)
5.4.1 Weigh 25.0 mg of di phenyl hydantoi n into a 25
mL class A volumetric flask.
5.4.2 Add MEOH to the mark and dissolve
compl etel y .
5. 5 Carbamazepine Standard, 1.0 mg/mL (25 mL)
5.5.1 Weigh 25.0 mg of carbamazepine into a 25 mL
class A volumetric flask.
5.5.2 Add MEOH to the mark and dissolve
compl etel y .
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5. 6 Hexobarbital Internal Standard. 1.0 mg/mL (25 mL).
5.5.1 Weigh 25.0 mg of hexobarbital into a 25 mL
class A volumetric flask.
5.5.2 Add ACN to the mark and dissolve completely.
6. Preparation of Working Anticonvulsant Standards for
Calibration (10 mL)
6. 1 Level 1 Ethosuximide at 25.0 pg/mL
Primidone at 5.0 pg/mL
Phenobarbital at 10.0 pg/mL
Di phenylhydantoi n at 10.0 pg/mL
Carbamazepine at 5.0 pg/mL
Hexobarbital at 20.0 pg/mL
6.1.1 Add the following volumes of the appropriate
1.0 mg/mL stock standard to a 10 mL class A
volumetric flask using an appropriate pipette.
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Ethosuximide - 250 uL
Primidone - 50 pL
Phenobarbital - 100 uL
Diphenyl hydantoin - 100 uL
Carbamazepine - 50 pL
Hexobarbital - 200 yL
6.1.2 Add eluent (prepared in section 4.4 ) to the
10 mL mark. Mix by inversion.
6. 2 Level 2: Ethosuximide at 100.0 pg/mL
Primidone at 20.0 pg/mL
Phenobarbital at 40.0 pg/mL
Diphenylhydantoin at 20.0 pg/mL
Carbamazepine at 20.0 pg/mL
Hexobarbital at 20.0 pg/mL
6.2.1 Add the following volumes of the appropriate
1.0 mg/mL stock standard to a 10 mL class A
volumetric flask using an appropriate pipette.
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Ethosuximide - 1000 uL
Primidone - 200 uL
Phenobarbital - 400 uL
Di phenyl hydantoi n - 200 pL
Carbamazepine - 200 pL
Hexobarbital - 200 pL
6.2.2 Add eluent (prepared in section 4.4) to the
10 mL mark. Mix by inversion.
7. Preparation of an "Unknown" Sample for Analysis
7.1 Add the following volumes of the appropriate
1.0 mg/mL stock standard to a 10 mL class A
volumetric flask using an appropriate pipette.
7.2
Ethosuximide - 500 pL
Primidone - 100 pL
Phenobarbital - 200 pL
Di phenyl hydantoi n - 150 pL
Carbamazepine - 100 pL
Hexobarbital - 200 pL
Add eluent (prepared in section 4.4) to the
10 mL mark. Mix by inversion.
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Anal ysi s
8. 1 Equipment Set-up
8.1.1 HP1090M and Workstation should be correctly
installed, configured, and operational. If
the system is not operational, refer to the
appropriate operators' manuals (42-45).
8.1.2 The solvent delivery system (SDS) should
already have been primed. If the solvent
system is not operational, refer to the
appropriate sections in the operator's
manual (46). This is usually done by pumping
degassed IPA through each solvent line at
5.0 mL/min for 3-5 minutes.
8.1.3 Load the degassed eluent prepared earlier
into the solvent compartment section
farthest to the left (pump A).
8.1.4 Install the appropriate guard cartridge and
analytical cartridge column.
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8. 2 Instrument Start-up
8.2.1 Turn on the electrical power to the
analytical workstation by switching on the
tan 6 outlet power strip located along the
wall behind the computer.
8.2.2 Turn on the electrical power to the
mainframe HPLC by pressing the POWER-ON
button located on the front panel in the
lower right corner.
8.2.3 Turn on the diode array detector (DAD) by
pressing the DETECTOR-ON button located
on the same panel. The deuterium lamp
requires 15-30 minutes warm-up time.
8.2.4 Turn on the Think Jet Printer. (The switch
is located in the back right corner).
8.2.5 Turn on the 20 MB hard drive (9153B) bv
depressing the rectangular button located in
front on the left side.
8.2.6 Turn on the CRT by depressing the
rectangular button located in front on the
lower left side.
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8.2.7 Turn on the computer by depressing the
rectangular button located in the -front on
the lower left side. Several screens
should automatically be displayed on the
CRT screen, indicating that memory is being
loaded, tested, and that the system is
booted .
8.2.8 The system should now be fully operational.
All operations and commands can now be
controlled from the keyboard. Please note
the keys labeled fl-f8 across the top of
the keyboard. They are essential to the
operation of this system and will be used
frequently to initiate operations described
in the green boxes viewed across the
bottom of the CRT screen. Each screen
viewed is called a form, which contains
several functions that can be initiated
through commands from the keyboard.
8.2.9 Verify the correct date on the bottom of
the CRT sceen. Proceed by pressing the
return key on the keyboard.
8.2.10 Verify the correct time. Proceed by
pressing the return key on the keyboard.
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8.3 Getting Ready to Run an Analysis - You are now in
the [Too Level 1 of a hierarchial tree of
functions (See Form Cl>.
8.3.1 Press F2, [Data Acquisition] to load the
data acquisition program.
8.3.2 The next screen (form) is the PREPARE TO
INJECT form (See Form C2> . Press F6, [EDIT
PARAMS].
8.3.3 You are now in the FILE INFORMATION form.
If the anticonvulsant parameter file is not
loaded (See Form C3), press Fl
[Load ParamsJ. You will be prompted to type
the name of a parameter file (See Form C4).
8.3.4 Type DATA: ANTICON. A over the previously
loaded parameter file name. (See Form C5>.
Press return. All the proper operating
parameters needed to assay the
anticonvulsants will be automatically
loaded. This includes the proper flow of
the pumps, run time, and detector wavelength
settings.
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FORM CI
HP 7 9 9 9 4 A
HPLC WORKSTATION
for HP 1040M
and HP 1090M
Copyright 1985, Hewlett-Packard Company
[TOP LEVEL]
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FORM C2
PREPARE TO INJECT
Data File Name : DATA:TEST1.D
Flow |jflffi 0.000 ml/mjn
SolvenT A 100.0 0.0 X
B 0.0 0.0 X
ci 0.0 0.0 X
7 May 88 12:31 pm
overwrite
narrow
Max Pressure : 400 0 bar
Stop Time : no limit 0.00 min
Contacts : 0000 0000
LC PRERUN
DAD PRERUN
MONITOR
EDIT,
PARRMS.
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FORM C3
FILE INFORMATION
PARAMETER FILE
Param. File Name DATA: TEST. A
Last Change Date 10 Apr 88 2:10 am
information :
Last~Altered By :
DATA FILE
Data File Name DATA:TEST1.D
Operator Name :
Sample Name :
Further Comments :
PARRMS I PARAMS
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FORM C4
FILE INFORMATION
PARAMETER FILE
DATA: TEST. ftParam. File Name
Last Change Date 10 Apr 88 2: 10 am
2nformation :
Last Altered By :
DATA FILE
Data File Name DATA:TEST1.D
Operator Name :
Sample Name :
Further Comments :
Load Parameter File - Enter a File Name or type
'?'
to list a disc volume
Escape-
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FORM C5
FILE INFORMATION
PARAMETER FILE
Param. File Name DATA: ANT] CON. A
Last Change Date 7 Feb 88 5:53 pm
2nformation : 54X(0.1M KH2P04.PH4.4), 46* MEOH C8, 5 UM, 210NM
Last'Altered By : GREGG C. HIDER
DATA FILE
Data File Name TEST1.D
Operator Name : STUDENT
Sample Name :
Further Comments : GETTING READY TO RUN h SAMPLE
ANTICONVULSANT DRUGS
PARRMSi PARflMS
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8.3.5 Turn on the SDS by pressing the PUMP ON
button at the front panel on the mainframe
of the HPLC. The column will need to
equilibrate for 10 minutes.
8.3.6 You should still be in the form titled
FILE INFORMATION. Pressing F5 CLC PARAMS ]
will allow you to verify that the proper LC
settings are loaded (See Form C6>. The A
pump flow should be set to 1.5 mL/min and
the run stop time should be 9.5 minutes.
Press FB to exit.
8.3.7 You should still be in the FILE INFORMATION
form. Pressing F6 [DAD PARMS1 will allow
you to verify that the detector is set at
the proper settings. The A signal should
be set to 210 nm (See Form C7) .
8. 3. S Press F8 to exit. You should still be in
the FILE INFORMATION form.
8.3.9 Press F8 [EXIT].
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FORM C6
LIQUID CHROMATOGRAPH initial parameters
Flow
SolvenT A
B
ci
Wagg ml/min
100. 0 X
off
off
Max Pressure 400 bar
Stop Time
Post Time
9.50 min
0.00 min
narrow
Min Pressure : off
Contacts : 0000
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FORM C7
DIODE-ARRAY DETECTOR
off
SIGNALS A B
Sample (nm)
Wavelength : 210 off
Bandwidth : 4
Reference (nm)
Wavelength : 550
Bandwidth : 100
Store Spectrum : peak controlled
Threshold : 10.0 mAU
Peakwidth : 0.100 min
Stop Time : same as LC
signals & spectra
E F G H
off off off off
about 115 Records acquired during Run
Sampling Interval 640 ms
Spectrum Range from : 210 nm
to : 400 nm
** Press <on> or <off> to set Signal **
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8. 4 Running an Analysis
8.4.1 You should now be in the PREPARE TO
INJECT form. Press the return key several
times until the highlighted area is moved
adjacent to the Data File Name field (See
Form C8) .
8.4.2 Type ANTSTD1.D. Press the return key.
This will create a new file name. This is
the name of your raw data file for vour
first standard injection.
8.4.3 Lift the cover on the HPLC exposing the
manual injector port and valve.
8.4.4 Fill a 250 pL Hamilton syringe with
standard level 1 prepared in section 6.1
8.4.5 Turn the injector valve to the load
position. The handle should be pointed at a
2 o'clock position.
8.4.6 Insert the needle all the way into the
injection port. Allow the syringe
barrel to lay on the black rest. Slowly
inject 200 pL of standard, observing
that liquid will drip into the waste
beaker. You have properly overfilled the
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FORM C8
PREPARE TO INJECT
Data File Name :
Flow
Solvent A
B
el
DATfl:TESTl.D
2.500 0.000 ml/min
100.0 0.0 X
off
off
7 May 88 12:57 pm
overwri te
: narrow
Max Pressure : 400 1 bar
Stop Time : 6.00 0.00 min
Contacts : 0000 0000
LC PRERUN
DAD PRERUN
* Enter a filename of up to 8 characters or
'?'
to list a disc volume **
MONITOR
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100 pL fixed sample loop which will
reduce the chances of carry-over from a
previous injection. Leave the syringe in
this posi ti on .
8.4.7 Carefully, but deliberately, turn the
injection valve to the inject position.
The handle should be pointed at a 4
o'clock position. A contact closure is
made and the run automatically begins and
will stop in 9.5 minutes.
8.4.8 You should still be in the PREPARE TO
INJECT form. You can view the
chromatography in a real time mode by
pressing F3 [MONITOR]. After 9.5 minutes,
press F8 [EXIT] to return to the PREPARE TO
INJECT form.
8.4.9 Using the return key, move the highlighted
area adjacent to the Data File Name field
(See Form C9> .
8.4.10 Type ANTSTD2.D. Press the return key.
This will create a new file name. This is
the name of your raw data file for your
second standard injection.
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FORM C9
PREPARE TD INJECT
Data File Name
Flow
Solvent A
B
CI
ANTSTD1.D
1.500 0.000 ml/min
100.0 0.0 X
off
off
7 May 88 5: 13 pm
overwri te
narrow
Max Pressure : 400 2 bar
Stop Time : 9.50 0.00 min
Contacts : 0000 0000
LC PRERUN
DAD PRERUN
* Enter a filename of up to 8 characters or
'?' to list a disc volume **
E9MONITOR
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8.4.11 Remove the syringe from the injection port.
8.4.12 Rinse the syringe well with methanol.
8.4.13 Fill a 250 pL Hamilton syringe with
standard level 2 prepared in section 6.2.
8.4.14 Once again, turn the injector valve to the
load position. The handle should be
pointed at a 2 o'clock, position.
8.4.15 Once again, insert the needle all the way
into the injection port. Allow the syringe
barrel to lay on the black rest. Slowly
inject 200 pL of standard observing that
liquid will drip into the waste beaker.
Leave the syringe in this position.
8.4.16 Once again, carefully, but deliberately
turn the injection valve to the inject
position at 4 o'clock. The run
automatically begins and will stop in 9.5
mi nutes .
8.4.17 You should still be in the PREPARE TO
INJECT form. Remember, you can view the
chromatography in a real time mode by
pressing F3 [MONITOR]. After 9.5 minutes,
press F8 [EXIT] to return to the PREPARE TO
INJECT form.
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8.4.18 Using the return key. move the highlighted
area adjacent to the Data File Name form
(See Form CIO). Type UNKN0WN3.D. Press
the return key. This will create a new
file name. This is the name of your
raw data file for your unknown sample
i n j ecti on .
8.4.19 Remove the syringe from the injection port.
8.4.20 Rinse the syringe well with methanol.
8.4.21 Fill a 250 uL Hamilton syringe with
unknown sample, prepared in section 7.
8.4.22 Inject the sample repeating steps
8.4. 14 thru 8.4. 20.
8.4.23 You should still be in the PREPARE TO
INJECT form. Remember, you can view the
chromatography in a real time mode by
hitting F3 [MONITOR]. After 9.5 minutes
press F8 [EXIT] to return to the PREPARE TO
INJECT form.
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FORM CIO
PREPARE TO INJECT
Data File Name :
Flow
Solvent A
B
CI
ANTSTD2.D
1.500 0.000 ml/min
100.0 0.0 X
off
off
7 May 88 5:14 pm
overwrite
: narrow
Max Pressure : 400 2 bar
Stop Time : 9.50 0.00 min
Contacts 00OO 0000
LC PRERUN
DAD PRERUN
** Enter a filename of up to 8 characters or
'?'
to list a disc volume **
MONITOR
.
PARAMS
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8.4.24 You are now done with the analysis part of
this laboratory procedure.
8.5 Calculate the Area Under the Peaks
8.5.1 You should still be in the PREPARE TO
INJECT form. Return to the top level
form by pressing F8 CQUIT1.
8.5.2 Press F3 [DATA EDITOR]. This is the area
where you may review your data, acquire
chromatograms, review retention times and
electronically acquire peak area data
(integrate) needed for quantitative work.
8.5.3 The first form you observe will prompt you
to type a file name. Type ANTSTD1.D and
press return. The computer will display
the chromatogram obtained for that sample
8.5.4 Go to the next form by pressing F4 [INTEG
KEYS].
C30
8.5.5 Press F3 [Integ.J. The area under each of
your peaks will be el ectroni cal 1 v
calculated (integrated).
8.5.6 Press the shift and print kevs
simultaneously to get a hard copy of your
integrated chromatogram displayed in this
form.
8.5.7 Press F4 [List Int Results] to obtain your
integrated data.
8.5.8 Press F5 [Send to Printer] to obtain a hard
copy.
8.5.9 Press F8 [Stop Tabulate] to go to the
previous form.
8.5.10 Press F8 [EXIT]. This will allow you to go
to a form that will allow you to change
your data file name.
8.5.11 Press Fl [New Data File]. You will again
be prompted to type a file name. Type
ANTSTD2.D and press return. The computer
will display the chromatogram obtained for
that sample.
8.5.12 Repeat steps 8.5.4 through 8.5.11. You
now have chromatograms and integrated peak
areas for all of your anticonvulsant
standards.
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8.5.13 Repeat steps 8.5.4 through 8.5.11 for
the unknown sample. Remember that the file
name is UNKN0WN3.D.
8.5.14 Press F8 [QUIT]. You are finished with the
data editor. You should now have
chromatograms and integrated peak areas
for the 3 samples injected in section 8.4
(See Figures 13-15).
Instrument Shut-down
9. 1 Flushing Out the System
9.1.1 Turn off the pump by using the on/off
buttons on the panel in the front of the
mainframe LC.
9.1.2 Switch the eluent bottle you have been
using with one containing HPLC-grade water.
9-1.3 Turn the pump on. Flush the system and
column for 10 minutes.
9-1.4 Turn off the pump .
9.1.5 Switch this water bottle with the one
containing 107. v/v methanol prepared in
section 4.5.
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FIGURE 13
Chromatogram and Intergrated Peak Area for Anticonvulsant
Standard Level 1
22B:
2BB
IBB"
IBB
MB:
12B:
IBB
BB:
BB:
4B
2B
Clnteql]
LC H 2 1 a. 4 55B. 1 BB Of RNTSTQ1
01 01
01
in
iJJ. 1
LC A 210,4 550,100
DATA:ANTSTD1 .0
4
T1 mo (nln.
T: LC A 210,4
Z: LC A 210,4
Y: null.
X: null.
550, 100
550,100
of ANTSTD1 .D
Peak* Ret Tine Type Width Area Start Time End Time
1 2.006 BV 0. 102 297. 88 1 .864 2.227
2 2.563 vB 0.123 783. 81 2.227 2.930
3 3.303 BB 0. 133 2009 3.068 3.686
4 6.079 Bv 0.192 2020 5.679 6.336
5 6.599 vB 0.210 2223 6.335 7.138
6 8.31 1 BB 0.249 1687 7.831 8.960
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FIGURE 14
Chromatogram and Intergrated Peak Area for Anticonvulsant
Standard Level 2
EBB
5BB-
4BB-
3BB
2BB
IBB
LC B 21 B. 4 55B, 1 BB of RNT5T02.D
jAw 1 WJ L+
4 E
T1 ma C m 1 n . }
[Inteql]
T: LC A 210,4 550,100
Z: LC A 210,4 550,100
Y: null.
X: null.
LC A 210, 4 550, 100 of A
ANTSTD2.D
Peak* Re t Time Type Width
1 1 .994 Bv 0. 154
2 2.541 vU 0.193
3 3.291 vB 0.208
4 6.119 Bv 0.245
5 6.518 vB 0.292
6 8.375 BB 0.313
Area
1174
2893
7790
2021
4053
6797
Start Time En d Time
1 .733 2.236
2.238 2.969
2.969 3.874
5.632 6.352
6.352 7.230
7.699 9.244
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FIGURE 15
Chromatogram and Intergrated Peak Area for Unknown
Sample Mix of Anticonvulsants
Clntegl]
T: LC A 215,4 550,100
Z: LC A 210,4 550.100
Y: null.
X: null.
Select
Signal:
LC A 210 ,4 550 100 of U
UNKN0WN3 D
Peak* Ret Time Type Width
1 2.012 BV 0.116
2 2.565 UB 0.138
3 3.308 BB 0.151
4 6.102 Bv 0.206
5 6.607 <JB 0.229
6 8.336 BB 0.264
Area Start Time End Time
593.61 1.825 2.241
1577 2.241 2.986
3853 3.050 3.764
2070 5.640 6.346
3186
3601
6.346
7.770
7.163
9.038
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9.1.6 Turn the pump on. Flush the system and
column for a minimum of 10 minutes.
9. 2 Shutting Down the System
9.2.1 Turn all the electrical components off in
exactly the reverse order that you turned
them on.
9.2.2 Be sure that the switch on the 6 outlet
power strip has been turned off.
10 Calculations
10. 1 Component Identification
Eluti on Order Compound
1 Ethosux i mi de
2 Pri mi done
3 Phenobarbi tal
4 Hexobarbi tal
5 Di phenyl hydantoi n
6 Carbamazepi ne
Retention Time (min)
2.01
2.56
3.31
6. 1 1
6.62
8.35
10.2 Peak Area Ratio (PAR) A separate peak area ratio
must be calculated for every compound in every
in ject i on .
Aix
PARix =
Ai<
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Where PARix = The peak area ratio for a
compound (x) within a sample
i n j ecti on ( i ) .
Where Aix = The peak area of a compound
(x) within a sample injection
(i ) .
Where Ais = The peak area of the
internal standard (s) within
a sample injection (i>.
10.3 Response Factor (Rf). A separate response factor
must be calculated for every compound.
Cix
Rfix =
PARix
Where Rfix = Response factor for a compound (x)
in standard (i) level 1 or 2.
Where Cix = Concentration (pg/mL) of a
compound (x) in standard (i) level 1 or
2 prepared in section 6.1 or 6.2.
10.4 Average Response Factor (RF) of Standard Level 1
and 2
Cix C2x
PARix PAR2x
RFx = =
Where RFx = The average response factor of
standard level 1 and 2 of a compound
(x) .
Where Cix = The Concentration (pg/mL) of a
compound (x> in standard level 1.
Where C2x = The Concentration (pg/mL) of a
compound (x) in standard level 2.
Where PARix = The peak area ratio of a compound
(x) in standard level 1.
Where PAR2x = The peak area ratio of a compound
(x) in standard level 2.
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10.5 Calculate the Concentration of a Compound in the
Unknown Sample
Cux = (RFx) (PARux)
Where Cux = The unknown concentration of a
compound (x) within the unknown sample
mix (u) prepared in section 7.
11. Sample Calculations (Data collected from Figures 13-15)
Peak #1 Compound Aix A2x Aux
1 Ethosuximide 298 1174 594
4 Hexobarbital 2020 2021 2070
11.1 Calculation of the Peak Area Ratios
Aix
PARix =
Ais
11.1.1 PAR for ethosuximide standard level 1
298
= = 0. 148
2020
11.1.2 PAR for ethosuximide standard level 2
1174
= = 0.581
2021
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11.2 Calculation of Response Factors (Rf)
Ci x
Rfix =
PARix
11.2.1 Response factor for ethosuximide standard
level 1
25.0 pg/mL
= = 168.9
0. 148
11.2.2 Response factor for ethosuximide standard
level 2
100.0 pg/mL
= = 172.1
0.581
11.3 Calculation of the Average Response Factor (RFx)
Rfix + Rf2x
RFx =
2
11.3.1 Calculation of the RFx for ethosuximide
168. 9 + 172. 1
= 170.5
11.4 Calculation of the Ethosuximide Concentration in
the Unknown Sample
594
PARix = = 0.287
2070
(RFx) (PARix) = (170.5) (0.287) = 48.9 pg/mL
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D. Simultaneous Hi ch-Perf ormance Liouid Chromatographic
Analvsis of Barbiturates
1. Introduct i on
1.1 Barbiturates are commonly used in combination
products to treat anxiety, gastrointestinal
distress, and sleep disorders (40). Barbiturates
are a structurally homogeneous group of compounds.
The barbiturates included in this study are
barbital, phenobarbital, butabarbital,
hexobarbital, mephobarbi tal , and secobarbital. The
basic structure of all the compounds investigated
in this procedure is barbituric acid. Alkyl and
aryl substitutions on this 6 membered ring moeity
confer specialized pharmacological properties. It
is these specific chemical substitutions that alter
these drugs' hydrophobi ci ty and enable one to
simultaneously separate each of these drugs in a
mixture using high-performance liquid
chromatography (HPLC) .
DI
2. Purpose
2.1 HPLC is a valuable analytical tool available for
the determination of blood and plasma levels of
barbiturates. The purpose of this laboratory
procedure is to familiarize the clinical chemistry
student with the basic operation of a semi -
automated high-performance liquid chromatograph so
that he can gain experience with this separation
technique and learn some practical analytical
skills.
3. Summary of Method
3.1 Barbital, phenobarbital, butabarbital,
hexobarbital, mephobarbi tal , and secobarbital are
dissolved in eluent and chromatogr aphed on an
Alltech C18 banded phase cartridge column. The
HPLC separation is done i socrati cal 1 y (a single
eluent system), in the reverse-phase mode.
Mixtures of the drugs are differentially
D2
partitioned on this column and clearly resolved.
Spectrophotometr i c detection is performed at 210
nm. Quantitation is done by mathematically
comparing detector response of drug standards to
unknowns. Hexobarbital, the internal standard, is
added to each sample at a constant level so that
small variations in technique, such as injection,
can be corrected.
Materials and Reagents
4. 1 Apparatus
4.1.1 A Hewlett-Packard high-performance liquid
chromatographic system was used for all
analytical work (Hewlett Packard,
Avondale, PA 19311-0900). The major
components housed within the mainframe of
this HP 1090 Series M liquid chromatograph
are an HP 1040M photodiode array detector, a
PV5 ternary solvent delivery system, and a
Rheodyne model 7010 manual injection valve.
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This system is controlled and monitored by
an HP 79994A Analytical Chemstation. The
central part of this Chemstation is the HP
9000 Series 300 computer. Other important
components included an HP 9153B 20 megabyte
Winchester disc drive with a separate disc
drive for 3.5 inch flexible discs, an HP
35741A color video monitor, keyboard, and an
HP 2225A Thinkjet printer. HP 79995A,
revision 3.11 operating software is also
used .
4.1.2 An Alltech Adsorbosphere HS C18, 7 pm 150
mm X 4.6 mm i.d. analytical cartridge column
was used (Alltech Associates, Inc.,
Deerfield, IL 60015., C/N. 35616).
4.1.3 An Alltech C18 guard cartridge column
was used to protect the analytical
column (Alltech Associates, Inc., C/N.
28015) .
4.1.4 Ranin model P-100 and P-1000 digital
pipettes were used. (Ranin Instrument
Company Inc., Woburn, MA 01801).
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4-2 Stock Reagents (All reagents are available from the
stockroom)
4.2.1 HPLC-grade water.
4.2.2 HPLC-grade methanol (MEOH).
4.2.3 HPLC-grade acetonitrile (ACN).
4.2.4 HPLC-grade isopropyl alcohol (IPA).
4.2.5 Reagent grade monobasic potassium
phosphate (KH2P04) .
4.2.6 Barbital (Sigma Chemical Company.
St. Louis, Mo 63178. Sigma No. B-0375).
4.2.7 Phenobarbital (Sigma Chemical Company.
Sigma No. P-1636) .
4.2.8 Butabarbital (Sigma Chemical Company.
Sigma No. B-8380) .
4.2.9 Hexobarbital (Sigma Chemical Company.
Sigma No. H-1005) .
4.2.10 Mephobarbi tal (Sigma Chemical Company.
Sigma No. M-3887) .
4.2.11 Secobarbital (Sigma Chemical Company.
Sigma No. S-1503) .
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4. 3 Stock 0.25 M Potassium Phosphate Buffer (ID
4.3.1 Add 3.40 g of KH2P04 into a IL graduated
cyl i nder .
4.3.2 Add HPLC-grade water to IL mark.
4.3.3 Stir until completely dissolved.
4.4 Eluent (ID 667. Stock Buffer (0.25 M KH2P04)
277. ACN
77. MEOH
4.4.1 In a IL graduated cylinder, add 660 mL of
the 0.25 M stock buffer prepared in section
4.3.
4.4.2 Add 270 mL of HPLC-grade ACN.
4.4.3 Add 70 mL of HPLC-grade MEOH.
4.4.4 Mix well, place in a IL HP solvent reservoir
bottle and degas under vacuum in a sonic-
bath for 1 minute.
4.5 Column Storage Solution (ID 107. v/v MEOH
4.5.1 In a IL graduated cylinder, add 100 mL of
HPLC-grade MEOH.
4.5.2 Add HPLC-grade water up to the IL mark.
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4.5.3 Mix well, place in a IL HP solvent reservoir
bottle and degas under vacuum in a sonic-
bath for 1 minute.
5. Stock Standards
5.1. Barbital Standard. 1.0 mg/mL (25 mL)
5.1.1 Weigh 25.0 mg of barbital into a 25 mL
class A volumetric flask.
5.1.2 Add MEOH to the mark and dissolve
compl etel y.
5. 2 Phenobarbital Standard. 1.0 mg/mL (25 mL)
5.2. 1 Weigh 25.0 mg of phenobarbital into a 25 mL
class A volumetric flask.
5.2.2 Add MEOH to the mark and dissolve
compl etel y -
5. 3 Butabarbital Standard. 1.0 mg/mL (25 mL)
5.3.1 Weigh 25.0 mg of butabarbital into a 25 mL
class A volumetric flask.
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5.3.2 Add MEOH to the mark and dissolve
compl etel y .
5. 4 Hexobarbital Internal Standard. 1.0 mg/mL (25 mL )
5.4.1 Weigh 25.0 mg of hexobarbital into a 25 mL
class A volumetric flask.
5.4.2 Add ACN to the mark and dissolve completely.
5.5. Mephobarbi tal Standard. 1.0 mg/mL (25 mL)
5.5.1 Weigh 25.0 mg of mephobarbarb i tal into a 25
mL class A volumetric flask.
5.5.2 Add MEOH to the mark and dissolve
compl etel y .
5.6. Secobarbital Standard, 1.0 mg/mL (25 mL)
5.6.1 Weigh 25.0 mg of secobarbital into a 25 mL
class A volumetric flask.
5.6.2 Add MEOH to the mark and dissolve
compl etel y -
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6. Preparation of Working Barbiturate Standards for
Calibration (10 mL >
6. 1 Level 1 Barbital at 20.0 pg/mL
Phenobarbital at 10.0 pg/mL
Butabarbital at 20.0 pg/mL
Mephobarbi tal at 3.0 pg/mL
Secobarbital at 5.0 pg/mL
Hexobarbital at 20.0 pg/mL
6.1.1 Add the following volumes of the appropriate
1.0 mg/mL stock standard to a 10 mL class A
volumetric flask using an appropriate
pi pette.
Barbital - 200 pL
Phenobarbital - 100 pL
Butabarbital - 200 pL
Mephobarbital - 30 pL
Secobarbital - 50 pL
Hexobarbital - 200 pL
6.1.2 Add eluent (prepared in section 4.4) to the
10 mL mark. Mix by inversion.
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6.2 Level 2: Barbital at 80.0 pg/mL
Phenobarbital at 40.0 pg/mL
Butabarbital at 40.0 pg/mL
Mephobarbital at 8.0 pg/mL
Secobarbital at 15.0 pg/mL
Hexobarbital at 20.0 pg/mL
6.2.1 Add the following volumes of the appropriate
1.0 mg/mL stock standard to a 10 mL class A
volumetric flask using an appropriate
pi pette.
Barbital - 800 pL
Phenobarbital - 400 pL
Butabarbital - 400 pL
Mephobarbital - 80 pL
Secobarbital - 150 pL
Hexobarbital - 200 pL
6.2.2 Add eluent (prepared in section 4.4) to the
10 mL mark. Mix by inversion.
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7. Preparation of an "Unknown" Sample tor Analvsis
7.1 Add the following volumes of the appropriate
1.0 mg/mL stack standard to a 10 mL class A
volumetric flask using an appropriate
pi pette.
Barbital - 400 pL
Phenobarbital - 200 pL
Butabarbital - 300 pL
Mephobarbital - 50 pL
Secobarbital - 100 pL
Hexobarbital - 200 pL
7.2 Add eluent (prepared in section 4.4) to the
10 mL mark. Mix by inversion.
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8. Anal ysi s
8. 1 Equipment Set-up
8.1.1 HP1090M and Workstation should be correctly
installed, configured, and operational. If
the system is not operational, refer to the
appropriate
operators'
manuals (42-45).
8.1.2 The solvent delivery system (SDS) should
already have been primed. If the solvent
system is not operational, refer to the
appropriate sections in the operator's
manual (46). This is usually done by
pumping degassed IPA through each solvent
line at 5.0 mL/min for 3-5 minutes.
8.1.3 Load the degassed eluent prepared earlier
into the solvent compartment section
farthest to the left (pump A).
8.1.4 Install the appropriate guard cartridge and
analytical cartridge column.
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8. 2 Instrument Start-up
8.2.1 Turn on the electrical power to the
analytical workstation by switching on the
tan 6 outlet power strip located along the
wall behind the computer.
8.2.2 Turn on the electrical power to the
mainframe HPLC by pressing the POWER-ON
button located on the front panel in the
lower right corner.
8.2.3 Turn on the diode array detector (DAD) by
pressing the DETECTOR-ON button located
on the same panel. The deuterium lamp
requires 15-30 minutes warm-up time.
8.2.4 Turn on the Think Jet Printer. (The switch
is located in the back right corner).
8.2.5 Turn on the 20 MB hard drive (9153B) by
depressing the rectangular button located in
front on the left side.
8.2.6 Turn on the CRT by depressing the
rectangular button located in front on the
lower left side.
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8.2.7 Turn on the computer by depressing the
rectangular button located in the front on
the lower left side. Several screens should
automatically be displayed on the CRT
screen, indicating that memory is being
loaded, tested, and that the system is
boated .
8.2.8 The system should now be fully operational.
All operations and commands can now be
controlled from the keyboard. Please note
the keys labeled fl-f8 across the top of
the keyboard. They are essential to the
operation of this system and will be used
frequently to initiate operations described
in the green boxes viewed across the
bottom of the CRT screen. Each screen
viewed is called a form, which contains
several functions that can be initiated
through commands from the keyboard.
8.2.9 Verify the correct date on the bottom of
the CRT screen. Proceed by pressing the
return key on the keyboard.
8.2.10 Verify the correct time. Proceed by
pressing the return key on the keyboard.
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8.3 Getting Ready to Run an Analysis - You are now in
the [Top Level ] of a hierarchial tree of
functions (See Form DI).
8.3.1 Press F2, [Data Acquisition] to load the
data acquisition program.
8.3.2 The next screen (form) is the PREPARE TO
INJECT form (See Form D2) . Press F6, [EDIT
PARAMS1.
8.3.3 You are now in the FILE INFORMATION form.
If the barbiturate parameter file is not
loaded (See Form D3) , press Fl [Load
Paramsl. You will be prompted to type the
name of a parameter file (See Form D4) .
8.3.4 Type DATA:BARBS.A over the previously
loaded parameter file name. (See Form D5) .
Press return. All the proper operating
parameters needed to assay the barbiturates
will be automatically loaded. This
includes the proper flow of the pumps, run
time, and detector wavelength settings.
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FORM DI
HP 7 9 9 9 4 A
HPLC WORKSTATION
for HP 1040M
and HP 1090M
Copyright 1985, Hewlett-Packard Company
[TOP LEVEL]
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FORM D2
PREPARE TO INJECT
Data File Name : DATA:TEST1.D
Flow HEBE 0.000 ml/min
vent A 100.0 0.0 X
B 0.0 0.0 X
ci 0.0 0.0 X
7 May 88 12:32 pm
overwri te
: narrow
Max Pressure : 400 1 bar
Stop Time : no limit 0.00 min
Contact: 0000 0000
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LC PRERUN
DAD PRERUN
I Start. E'1T_PfiRRHS
FORM D3
FILE INFORMATION
PARAMETER FILE
Param. File Name DATA: TEST. A
Last Change Date 10 Apr 88 2:10 am
2nformation :
Last Altered By :
DATA FILE
Data File Name DATA:TEST1.D
Operator Name :
Sample Name :
Further Comments :
IO
PARflMS I PARAHS
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FORM D4
FILE INFORMATION
PARAMETER FILE
Param. File Name
Last Change Date 10 Apr^3S 2:10 am
2nformation :
Last Altered By :
DATA FILE
Data File Name DATft:TESTl.D
Operator Name
Sample Name
Further Comments
Load Parameter File - Enter a File Name or type '?' to list a disc volume
Escape
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FORM D5
FILE INFORMATION
PARAMETER FILE
Param. File Name DATA: BARBS. A
Last Change Date 5 Jan 83 10:06 pm
Information : 66* 25 mM. KH2P04CPH 4.9), 27X ACN, 7X MEOH, 2 mL/MlN. 205NM.
LasfAltered By : GREGG C. HIDER
DATA FILE
Data File Name TEST1.D
Operator Name : STUDENT
Sample Name
_^_^^^____
Further Comments : GETTING READY TO RUN A iflMPLE
BARBITURATES
PARAMS I PARAMS
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8.3.5 Turn on the SDS by pressing the PUMP ON
button at the front panel on the mainframe
of the HPLC. The column will need to
equilibrate for 10 minutes.
8.3.6 You should still be in the FILE INFORMATION
form. Pressing F5 CLC PARAMS] will allow
you to verify that the proper LC settings
are loaded (See Form D6). The A pump flow
should be set to 1.0 mL/min and the run
stop time should be 10.0 minutes. Press F8
to ex i t .
8.3.7 You should still be in the FILE
INFORMATION form. Pressing F6 [DAD
PARMS] will allow you to verify that the
detector is set at the proper settings.
The A signal should be set to 205 nm (See
Form D7> .
3.3.8 Press F8 to exit. You should still be in
the. FILE INFORMATION form.
8.3.9 Press F8 [EXIT].
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FORM D6
LIQUID CHROMATOGRAPH initial parameters
Flow
SolvenT A
B
cT
222? ml/min
100.0 X
off
off
Max Pressure 400 bar
Stop Time
Post Time
10.00 min
0.00 min
narrow
Min Pressure : off
Contacts : 0000
LC TIME
TABLE
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FORM D7
DIODE-ARRAY DETECTOR
B C
off off
SIGNALS A
Sample (nm)
Wavelength : gjg
Bandwidth : 4
Reference (nm)
Wavelength : 550
Bandwidth : 100
signals & spectra
D E F G H
off off off off off
Store Spectrum : peak controlled about 122 Records acquired during Run
Threshold : 10.0 mAU
Peakwidth : 0.100 min
Stop Time : same as LC
Sampling Interval 640 ms
Spectrum Range from : 210 nm
"
to : 400 nm
MONITOR
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8. 4 Running an Analysis
8.4.1 You should now be in the PREPARE TO
INJECT form. Press the return key several
times until the highlighted area is moved
adjacent to the Data File Name field (See
Form D8) .
8.4.2 Type BARBSTD1.D. Press the return key.
This will create a new file name. This is
the name of your raw data file for your
first standard injection.
8.4.3 Lift the cover on the HPLC exposing the
manual injector port and valve.
8.4.4 Fill a 250 pL Hamilton syringe with
standard level 1 prepared in section 6.1
8.4.5 Turn the injector valve to the load
position. The handle should be pointed at a
2 o'clock position.
8.4.6 Insert the needle all the way into the
injection port. Allow the syringe
barrel to lay on the black rest. Slowly
inject 200 pL of standard, observing
that liquid will drip into the waste
beaker. You have properly overfilled the
D24
FORM DB
PREPARE TO INJECT
Data File Name
Flow
Solvent A
B
Ci
DATA:TEST1.D
2.500 0.000 ml/min
100.0 0.0 X
off
off
7 May 88 12:57 pm
overwri te
: narrow
Max Pressure : 400 1 bar
Stop Time : 6.00 0.00 min
Contacts : 0000 0000
LC PRERUN
DAD PRERUN
** Enter a filename of up to 8 characters or
'?'
to list disc vohjmej**
MONITOR
EDIT -
PARAMS
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fixed sample loop which will reduce the
chances of carry-over from a previous
injection. Leave the syringe in this
posi t i on .
8.4.7 Carefully, but deliberately turn the
injection valve to the inject position.
The handle should be pointed at a 4
o'clock position. A contact closure is
made and the run automatically begins and
will stop in 10.0 minutes.
8.4.8 You should still be in the PREPARE TO
INJECT form. You can view the
chromatography in a real time mode by
pressing F3 [MONITOR]. After 10.0 minutes,
press FS [EXIT] to return to the PREPARE TO
INJECT form.
8.4.9 Using the return key, move the highlighted
area adjacent to the Data File Name field
(See Form D9) .
8.4.10 Type BARBSTD2.D. Press the return key.
This will create a new file name. This is
the name of your raw data file for your
second standard injection.
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FORM D9
PREPARE TO INJECT
Data File Name :
Flow
SolvenT A
B
Ci
BARBSTD1.D
2.000 0.00D ml/min
100.0 0.0 2
off
off
7 May 88 5:04 pm
overwri te
: narrow
Max Pressure : 400 3 bar
Stop Time : 10.00 0.00 min
Contacts 0000 0000
LC PRERUN
DAD PRERUN
** Enter a filename of up to 8 characters or
'?'
to list a disc volume **
MONITOR
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8.4.11 Remove the syringe from the injection port.
8.4.12 Rinse the syringe well with methanol.
8.4.13 Fill a 250 pL Hamilton syringe with
standard level 2 prepared in section 6.2.
8.4.14 Once again, turn the injector valve to the
load position. The handle should be
pointed at a 2 o'clock position.
8.4.15 Once again, insert the needle all the way
into the injection port. Allow the syringe
barrel to lay on the black rest. Slowly
inject 200 pL of standard observing that
liquid will drip into the waste beaker.
Leave the syringe in this position.
8.4.16 Once again, carefully, but deliberately,
turn the injection valve to the inject
position at 4 o'clock. The run
automatically begins and will stop in 10.0
mi nutes.
8.4.17 You should still be in the PREPARE TO
INJECT form. Remember, you can view
the chromatography in a real time mode by
pressing F3 [MONITOR]. After 10.0 minutes,
press FB [EXIT] to return to the PREPARE TO
INJECT form.
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8.4.18 Using the return key, move the highlighted
area adjacent to the Data File Name form
(See Form D10). Type UNKN0WN4.D. Press
the return key- This will create a new
file name. This is the name of your
raw data file for your unknown sample
i n j ecti on .
8.4.19 Remove the syringe from the injection port.
8.4.20 Rinse the syringe well with methanol.
8.4.21 Fill a 250 pL Hamilton syringe with
unknown sample, prepared in section 7-
8.4.22 Inject the sample repeating steps
8. 4. 14 thru 8. 4.20.
8.4.23 You should still be in the PREPARE TO
INJECT form. Remember, you can the
view the chromatography in a real time
mode by pressing F3 [MONITOR]. After 10.0
minutes press F8 [EXIT] to return to the
PREPARE TO INJECT form.
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FORM DIP
PREPARE TO INJECT
Data File Name :
Flow
Solvent A
B
CI
BARBSTD2.D -
2.000 0.000 ml/min
100.0 0.0 X
off
off
7 May 88 5:05 pm
overwri te
narrow
Max Pressure : 400 0 bar
Stop Time : ID. 00 0.00 min
Contacts : 0000 00D0
LC PRERUN
DAD PRERUN
** Enter a filename of up to 8 characters or
'?'
to list a disc volume **
IMONITOR Stop<- ,ED1T;Run: I PARAMS
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8.4.24 You are now done with the analysis part of
this laboratory procedure.
8. 5 Calculate the Area Under the Peaks
8.5.1 You should still be in the PREPARE TO
INJECT form. Return to the top level
form by pressing F8 [QUIT].
8.5.2 Press F3 [DATA EDITOR]. This is the area
where you may review your data, acquire
chromatograms, review retention times and
electronically acquire peak area data
(integrate) needed for quantitative work.
8.5.3 The first form you observe will prompt you
to type a file name. Type BARBSTD1.D and
press return. The computer will display
the chromatogram obtained for that sample
8.5.4 Go to the next form by pressing F4 [INTEG
KEYS].
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8.5.5 Press F3 Clnteg.J The area under each of
your peaks will be electronically
calculated (integrated).
8.5.6 Press the shift and print keys
simultaneously to get a hard copy of your
integrated chromatogram displayed in this
form.
8.5.7 Press F4 [List Int Results] to obtain your
integrated data.
8.5.8 Press F5 CSend to Printer! to obtain a hard
copy.
8.5.9 Press F8 [Stop Tabulate] to go to the
previous form.
8.5.10 Press F8 [EXIT]. This will allow you to go
to a form that will allow you to change
your data file name.
8.5.11 Press Fl [New Data File]. You will again
be prompted to type a file name. Type
BARBSTD2.D and press return. The computer
will display the chromatogram obtained for
that sample.
8.5.12 Repeat steps 8.5.4 through 8.5.11. You
now have chromatograms and integrated peak
areas for all your barbiturate standards.
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8.5.13 Repeat steps 8.5.4 through 8.5.11 for
the unknown sample. Remember that the file
name is UNKN0WN4.D.
8.5.14 Press F8 [QUIT]. You are finished with the
data editor. You should now have
chromatograms and integrated peak areas
for the 3 samples injected in section 8.4
(See Figures 16-18).
9. Instrument Shut-down
9. 1 Flushing Out the System
9. 1. 1 Turn off the pump by using the on/off
buttons on the panel in the front of the
mainframe LC.
9.1.2 Switch the eluent bottle you have been
using with one containing HPLC-grade water.
9.1.3 Turn the pump on. Flush the system and
column for 10 minutes.
9.1.4 Turn off the pump .
9.1.5 Switch this water bottle with the one
containing 107. v/v methanol prepared in
section 4.5.
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FIGURE 16
Chromatogram and Intergrated Peak Area for Barbiturate
Standard Level 1
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FIGURE 17
Chromatogram and Intergrated Peak Area for Barbiturate
Standard Level 2
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FIGURE 18
Chromatogram and Intergrated Peak Area for Unknown
Sample Mix of Barbiturates
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9.1.6 Turn the pump on. Flush the system ana
column for a minimum of 10 minutes.
9. 2 Shutting Down the System
9.2.1 Turn all the electrical components off in
exactly the reverse order that you turned
them on.
9.2.2 Be sure that the switch on the 6 outlet
power strip has been turned off.
10. Cal cul ati ons
10. 1 Component Identification
El ut i on Or der Compound
1 Barbital
2 Phenobarbi tal
3 Butabarbi tal
4 Hexobarbi tal
5 Mephobarbi tal
6 Secobarbi tal
Retention Time (min)
1.59
3.00
3.39
5.87
6.65
8. 17
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10.2 Peak Area Ratio (PAR). a separate peak area ratio
must be calculated for every compound in every
i n j ect i on .
PARix =
Aix
Ai<
Where PARix = The peak area ratio for a
compound (x) within a sample
in jecti on (i ) .
Where Aix = The peak area of a compound
(x> within a sample injection
(i ) .
Where Ais = The peak area of the
internal standard (s) within
a sample injection (i>.
10.3 Response Factor (Rf). A separate response factor
must be calculated for every compound.
Cix
Rfix =
PARix
Where Rfix = Response factor for a compound (x>
in standard (i) level 1 or 2.
Where Cix = Concentration (pg/mL) of a
compound (x) in standard (i) level 1 or
2 prepared in section 6.1 or 6.2.
10.4 Average Response Factor (RF) of Standard Level 1
and 2
Cix C2x
PARix PAR2x
RFx = ========
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Where RFx = The average response factor of
standard level 1 and 2 of a compound
(x ) .
Where Cix = The Concentration (pg/mL) of a
compound (x) in standard level 1.
Where C2x = The Concentration (pg/mL) of a
compound (x) in standard level 2.
Where PARix = The peak area ratio of a compound
(x) in standard level 1.
Where PAR2x = The peak area ratio of a compound
(x) in standard level 2.
10> 5 Calculate the Concentration of a Compound in the
Unknown Sampl e
Cux = (RFx) (PARux)
Where Cux = The unknown concentration of a
compound (x> within the unknown sample
mix (u) prepared in section 7.
11. Sample Calculations (Data collected from Figures 16-18)
Peak ttl Compound Aix A2x Aux
1 Barbital 2044 8576 4097
4 Hexobarbital 2101 2248 2050
11.1 Calculation of the Peak Area Ratios
Aix
PARix =
Ais
11.1.1 PAR for barbital standard level 1
2044
= = 0.973
2101
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11.1.2 PAR for barbital standard level 2
8576
2148
= 3.993
11.2 Calculation of the Response Factors (Rf)
Cix
Rfix =
PARix
11.2.1 Response factor for barbital standard
level 1
20.0 pg/mL
= = 20.55
0.973
11.2.2 Response factor for barbital standard
level 2
80.0 pg/mL
= = 20.04
3.993
11.3 Calculation of the Average Response Factor (RFx)
Rfix + Rf2x
RFx =
2
11.3.1 Calculation of the RFx for barbital
20.55 + 20.04
= 20.30
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11.4 Calculation of the Barbital Concentration in the
Unknowh Sample
4097
PARix = = 1.999
2050
(RFx) (PARix) = (20.30) (1.999) = 40.6 pg/mL
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E. Simultaneous Hi gh-Perf ormance Liauid Chromatographic
Analysis of Theophylline and Related Methyl xanthi nes
Introduct i on
1.1 Theophylline, caffeine and theobromine are closely
related, both in structure and pharmacological
properties. These 3 compounds are methylated
xanthines. They act as central nervous system
stimulants, stimulate cardiac muscle, and relax
smooth muscles. Theophylline is a popular drug
used in the treatment of asthma and chronic
obstructive pulmonary disease. Many caffeine
containing beverages such as tea also contain small
amounts of theophylline and theobromine.
Theophyl ine and theobromine are metabolic
intermediates in the hepatic metabolism of
caffeine. Clinically, there seldom is a need to
monitor blood or serum levels of any of the
methylxanthines other than theophylline. However,
one should recognize that these and other
methylated xanthines can represent potential
interferents in the measurement of theophylline
1 evel s.
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2. Purpose
2.1 HPLC is a valuable analytical tool available for
the determination of interference free serum or
plasma levels of theophylline. The purpose of this
laboratory procedure is to familiarize the
clinical chemistry student with the basic operation
of a semi -automated high-performance liquid
chromatograph so that he can gain experience with
this separation technique and learn some
practical analytical skills.
3. Summary of Method
3.1 Theobromine, theophylline, caffeine, and
|3-hydroxethyl theophyl 1 ine are dissolved in
eluent and chromatographed on an Alltech C8 bonded
phase cartridge column. The HPLC separation is
done i socrati cal 1 y (a single eluent system), in the
reverse-phase mode. Mixtures of the drugs are
differentially partitioned on this column and
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clearly resolved. Spectrophotometr i c detection is
performed at 210 nm. Quantitation is done bv
mathematically comparing detector response of drug
standards to unknowns. (3-hydroxethyl -
theophylline, the internal standard, is added to
each sample at a constant level so that small
variations in technique, such as sample injection,
can be corrected.
4. Materials and Reagents
4. 1 Apparatus
4.1.1 A Hewlett-Packard high-performance liquid
chromatographic system was used for all
analytical work (Hewlett Packard,
Avondale, PA 19311-0900). The major
components housed within the mainframe Df
this HP 1090 Series M liquid chromatograph
are an HP 1040M photodiode array detector, a
PV5 ternary solvent delivery system, and a
Rheodyne model 7010 manual injection valve.
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This system is controlled and monitored by
an HP 79994A Analytical Chemstation. The
central part of this Chemstation is the HP
9000 Series 300 computer. Other important
components included an HP 9153B 20 megabyte
Winchester disc drive with a separate disc
drive for 3.5 inch flexible discs, an HP
35741A color video monitor, keyboard, and an
HP 2225A Thinkjet printer. HP 79995A,
revision 3.11 operating software is also
used .
4.1.2 An Alltech Econosphere C8, 5 pm 150 mm
X 4.6 mm i.d. analytical cartridge column
was used (Alltech Associates, Inc.,
Deerfield, IL 60015., C/N. 71012).
4.1.3 An Alltech CS guard cartridge column
was used to protect the analytical
column (Alltech Associates, Inc. C/N.
28017) .
4.1.4 Ranin model P-100 and P-1000 digital
pipettes were used. (Ranin Instrument
Company Inc., Woburn, MA 01801).
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4.2 Stock Reagents (All reagents are available from the
stockroom)
4.2.1 HPLC-grade water.
4.2.2 HPLC-grade methanol (MEOH).
4.2.3 HPLC-grade acetonitrile (ACN).
4.2.4 HPLC-grade isopropyl alcohol (IPA).
4.2.5 HPLC-grade tetrahydrofuran (THF).
4.2.6 Reagent grade monobasic potassium
phosphate (KH2P04) .
4.2.7 Theobromine (Sigma Chemical Company. St.
Louis, Mo. 63178. Sigma No. T-4500) .
4.2.8 Theophylline (Sigma Chemical Company.
Sigma No. T-1633).
4.2.9 ft-Hydroxethyl theophyl 1 i ne (Sigma Chemical
Company. Sigma No. H-9006).
4.2.10 Caffeine (Sigma Chemical Company. Sigma No.
C-0705) .
4. 3 Stock 0.10 M Potassium Phosphate Buffer (ID
4.3.1 Add 1.36 g of KH2P04 into a IL graduated
cyl inder .
4.3.2 Add HPLC-grade water to IL mark.
4.3.3 Stir until completely dissolved.
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4.4 Eluent (ID: 947. Stock Buffer (0.10 M KH2P04)
47. ACN
27. THF
4.4.1 In a IL graduated cylinder, add 940 mL of
the 0.10 M stock buffer prepared in section
4.3.
4.4.2 Add 40 mL of HPLC-grade ACN.
4.4.3 Add 20 mL of HPLC-grade THF.
4.4.4 Mix well, place in a IL HP solvent reservoir
bottle and degas under vacuum in a sonic-
bath for 1 minute.
4.5 Column Storage Solution (ID 107. v/v MEOH
4.5.1 In a IL graduated cylinder, add 100 mL of
HPLC-grade MEOH.
4.5.2 Add HPLC-grade water up to the IL mark.
4.5.3 Mix well, place in a IL HP solvent reservoir
bottle and degas under vacuum in a
sonic-
bath for 1 minute.
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Stock Standards
5.1. Theobromine Standard. 0.40 mg/mL (25 mL)
5.1.1 Weigh 10.0 mg of theobromine into a 25 mL
class A volumetric flask.
5.1.2 Add eluent (prepared in section 4.4) to the
mark and dissolve completely.
5. 2 Theophylline Standard. 1.0 mg/mL (25 mL)
5.2.1 Weigh 25.0 mg of theophylline into a 25 mL
class A volumetric flask.
5.2.2 Add eluent (prepared in section 4.4) to the
mark and dissolve completely.
5. 3 fl-Hydroxethyltheophyl 1 ine Internal Standard, 1.0
mg/mL (25 mL)
5.3.1 Weigh 25.0 mg of ft-Hydroxethyl theophyl 1 i ne
into a 25 mL class A volumetric flask.
5.3.2 Add eluent (prepared in section 4.4) to the
mark and dissolve completely.
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5. 4 Caffeine Standard, 1.0 mg/mL (25 mL)
5.4.1 Weigh 25.0 mg of caffeine into a 25 mL
class A volumetric flask.
5.4.2 Add eluent (prepared in section 4.4) to the mark
and dissolve completely.
6. Preparation of Working Methylxanthine Standards for
Cal ibration ( 10 mL)
6. 1 Level 1: Theobromine at 5.0 pg/mL
Theophylline at 5.0 pg/mL
Caffeine at 5.0 pg/mL
ft-Hydroxethyl theophyl 1 i ne at 15.0 pg/mL
6.1.1 Add the following volumes of the appropriate
1.0 mg/mL stock standard to a 10 mL class A
volumetric flask using an appropriate
pi pette.
Theobromine - 125 pL
Theophylline - 50 pL
Caffeine - 50 pL
fi-Hydroxethyltheophyl 1 ine - 150 pL
EB
6.1.2 Add eluent (prepared in section 4.4) to the
10 mL mark. Mix by inversion.
6 . 2 Level 2 : Theobromine at 20.0 pg/mL
Theophylline at 25.0 pg/mL
Caffeine at 20.0 pg/mL
|3-Hydroxethyl theophyl 1 i ne at 15.0 pg/mL
6.2.1 Add the following volumes of the appropriate
1.0 mg/mL stock standard to a 10 mL class A
volumetric flask using an appropriate
pi pette.
Theobromine - 500 pL
Theophylline - 250 pL
Caffeine - 200 pL
(3-Hydroxethyl theophyl 1 ine - 150 pL
6.2.2 Add eluent (prepared in section 4.4) to the
10 mL mark. Mix by inversion.
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7. Preparation of an "Unknown" Sample for Analysi
7.1 Add the following volumes of the appropriate
1.0 mg/mL stock standard to a 10 mL class A
volumetric flask using an appropriate
pi pette.
Theobromine - 250 pL
Theophylline - 100 pL
Caffeine - 100 pL
ft-Hydroxethyl theophyl 1 ine - 150 pL
7.2 Add eluent (prepared in section 4.4) to the 10 mL
mark. Mix by inversion.
8. Anal vsi s
8. 1 Equipment Set-up
8.1.1 HP1090M and Workstation should be correctly
installed, configured, and operational. If
the system is not operational, refer to the.
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appropriate operators' manuals (42-45).
8.1.2 The solvent delivery system (SDS) should
already have been primed. If the solvent
system is not operational, >-efer to the
appropriate sections in the operator's
manual (46). This is usually done by pumping
degassed IPA through each solvent line at
5.0 mL/min for 3-5 minutes.
8.1.3 Load the degassed eluent prepared earlier
into the solvent compartment section
farthest to the left (pump A).
8.1.4 Install the appropriate guard cartridge and
analytical cartridge column.
8. 2 Instrument Start-up
8.2.1 Turn on the electrical power to the
analytical workstation by switching on the
tan 6 outlet power strip located along the
wall behind the computer.
8.2.2 Turn on the electrical power to the
mainframe HPLC by pressing the POWER-ON
button located on the front panel in the
lower right corner.
Ell
8.2.3 Turn on the diode array detector (DAD) by
pressing the DETECTOR-ON button located
on the same panel. The deuterium lamp
requires 15-30 minutes warm-up time.
8.2.4 Turn on the Think Jet Printer. (The switch
is located in the back right corner).
8.2.5 Turn on the 20 MB hard drive (9153B) by
depressing the rectangular button located in
front on the left side.
8.2.6 Turn on the CRT by depressing the
rectangular button located in front on the
lower left side.
8.2.7 Turn on the computer by depressing the
rectangular button located in the front on
the lower left side. Several screens
should automatically be displayed on the
CRT screen, indicating that memory is being
loaded, tested, and that the system is
booted.
8.2.8 The system should now be fully operational.
All operations and commands can now be
controlled from the keyboard. Please note
the keys labeled fl-f8 across the top of
the keyboard. They are essential to the
operation of this system and will be used
frequently to initiate operations described
E12
in the green boxes viewed across the
bottom of the CRT screen. Each screen
viewed is called a form, which contains
several functions that can be initiated
through commands from the keyboard
8.2.9 Verify the correct date on the bottom of
the CRT sceen. Proceed by pressing the
return key on the keyboard.
8.2.10 Verify the correct time. Proceed by
pressing the return key on the keyboard.
8.3 Getting Ready to Run an Analysis - You are now in
the CTop Level ] of a hierarchial tree of
functions (See Form El).
8.3.1 Press F2, [Data Acquisition] to load the
data acquisition program.
8.3.2 The next screen (form) is the PREPARE TO
INJECT form (See Form E2> . Press F6, CEDIT
PARAMS].
8.3.3 You are now in the FILE INFORMATION form.
If the methylxanthine parameter file is not
loaded (See Form E3) , press Fl [Load
Paramsl. You will be prompted to type the
name of a parameter file (See Form E4).
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FORM El
HP 79994A
HPLC WORKSTATION
for HP 1O40H
and HP 1090M
Copyright 1985, Hewlett-Packard Company
[TOP LEVEL]
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FORM E2
PREPARE TO INJECT
Data File Name : DATA:TEST1.D
0.000 ml/minFlow
SolvenT A
B
ci
100.0
o.o
o.o
O.O X
0.0 X
0.0 X
7 May 88 12:31 pm
overwri te
: narrow
Max Pressure : 400 0 bar
Stop Time : no limit 0.00 min
Contacts : 0000 0000
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LC PRERUN
DAD PRERUN
MONITOR
FORM E3
FILE INFORMATION
PARAMETER FILE
Param. File Name DATA: TEST. A
Last Change Date 10 Apr 88 2:10 am
2nformation :
Last Altered By :
DATA FILE
Data File Name DATA: TEST l.D
Operator Name :
Sample Name :
Further Comments :
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FORM E4
FILE INFORMATION
PARAMETER FILE
Param. File Name
Last Change Date 10 Apr 88 2: 10 am
2nformation :
Last Altered By :
DATA FILE
Data File Name DATA:TEST1.D
Operator Name :
Sample Name :
Further Comments :
Load Parameter File - Enter a File Name or type
'?'
to list a disc volume
Esqape-
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8.3.4 Type DATA:XANTH.A over the previously
loaded parameter file name. (See Form E5>.
Press return. All the proper operating
parameters needed to assay theophylline and
the related methyl xanthi nes will be
automatically loaded. This includes the
proper flow of the pumps, run time, and
detector wavelength settings.
8.3.5 Turn on the SDS by pressing the PUMP ON
button at the front panel on the mainframe
of the HPLC. The column will need to
equilibrate for 10 minutes.
8.3.6 You should still be in the FILE INFORMATION
form. Pressing F5 LLC PARAMS] will allow
you to verify that the proper LC settings
are loaded (See Form E6). The A pump flow
should be set to 1.5 mL/min and the run stop
time should be 6.0 minutes. Press F8 to
exit.
8.3.7 You should still be in the FILE INFORMATION
form. Pressing F6 [DAD PARMS] will allow
you to verify that the detector is set at
the proper settings. The A signal should be
set to 210 nm (See Form E7) .
E1B
FORM E5
FILE INFORMATION
PARAMETER FILE
Param. File Name DATA:XANTH.A
Last Change Date 23 Dec 87 6:13 pm
Information : 94* lOmM KH2P04 pH 5.05, 4X ACN, ZX THF, 1.5 ML/MIN. 210 NM
Altered ey : GREGG C. HIDER
DATA FILE
Data File Name DATA:TEST1.D
Operator Name : STUDENT
Sample Name :
Further Comments : GETTING READY TO RUN A SAMPLE
THEOPHYLLINE AND RELATED METHYLXANTHINES -
PARAMS. I PARAMS.
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FORM E6
LIQUID CHROMATOGRAPH initial parameter:
Flow
SolvenT A
B
ci
Mg5K ml/mm
100.0 X
0.0 X
0.0 X
Max Pressure 400 bar
Stop Time
Post Time
6.00 mm
0.00 mm
: narrow
Min Pressure : off
Contacts : 0000
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FORM E7
D 1 0 D E - A R FI A Y D E TEC!1 D R signals 5c spectra
SIGNALS A B C D E F G H
Sample (nm)
Wavelength : SE off off off off off off off
Bandwidth : 4
Reference (nm)
Wavelength : 550
Bandwidth : 100
Store Spectrum : peak controlled about 76 Records acquired during Run
Threshold : 10.0 mAU
Peakwidth : 0.100 min Sampling Interval 640 ms
Stop Time : same as LC Spectrum Range from : 210 nm
~
to : 400 nm
MONITOR
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8.3.8 Press F8 to exit. You should still be in
the FILE INFORMATION form.
8.3.9 Press FS [EXIT].
8. 4 Running an Analysis
8.4.1 You should now be in the PREPARE TO INJECT
form. Press the return key several times
until the highlighted area is moved
adjacent to the Data File Name field (See
Form E8> .
8.4.2 Type XANSTD1.D. Press the return key.
This will create a new file name. This is
the name of your raw data file for your
first standard injection.
8.4.3 Lift the cover on the HPLC exposing the
manual Injector port and valve.
8.4.4 Fill a 250 pL Hamilton syringe with
standard level 1 prepared in section 6.1
8.4.5 Turn the injector valve to the load
position. The handle should be painted at a
2 o'clock position.
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FORM E8
PREPARE TO INJECT
Fi le Name DATA:TEST1.D-
Flow
SolvenT A
B
cT
2.500 0.000 ml/min
100.0 0.0 X
off
off
7 May 88 12:57 pm
overwri te
narrow
Max Pressure : 400 1 bar
Stop Time : 6.00 0.00 mm
Contacts : 0000 0000
LC PRERUN
DAD PRERUN
** Enter a filename of up to 8 characters or
'?'
to list a disc volume **
MONITOR
Stop-
.EDIT.
Runi'/'I PARAMS
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8.4.6 Insert the needle all the wav into the
injection port. Allow the syringe
barrel to lay on the black rest. Slowly
inject 200 pL of standard, observing
that liquid will drip into the waste
beaker. You have properly overfilled the
10 pL fixed sample loop which will
reduce the chances of carry-over from a
previous injection. Leave the syringe in
this position.
8.4.7 Carefully, but deliberately, turn the
injection valve to the inject position.
The handle should be pointed at a 4
o'clock position. A contact closure is
made and the run automatically begins and
will stop in 6.0 minutes.
8.4.8 You should still be in the PREPARE TO
INJECT form. You can view the
chromatography in a real time mode by
pressing F3 [MONITOR]. After 6.0 minutes,
press F8 [EXIT! to return to the PREPARE TO
INJECT form.
8.4.9 Using the return key, move the highlighted
area adjacent to the Data File Name field
(See Form E9) .
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FORM E9
PREPARE TO INJECT
Data File Name :
Flow
SolvenT A
B
cT
KANSTD1.D
1.500 0.000 ml/min
100.0 0.0 X
0.0 0.0 X
0.0 0.0 X
7 May 88 4:50 pm
overwri te
narrow
Max Pressure :
Stop Time :
400 1 bar
6.00 0.00 mm
Contacts : 0000 0000
LC PRERUN
DAD PRERUN
** Enter a filename of up to 8 characters or
"?' to list a disc volume **
MONITOR
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8.4.10 Type XANSTD2.D. Press the return key.
This will create a new file name. This is
the name of your raw data file for your
second standard injection.
8.4.11 Remove the syringe from the injection port.
8.4.12 Rinse the syringe well with methanol.
8.4.13 Fill a 250 pL Hamilton syringe with
standard level 2 prepared in section 6.2.
8.4.14 Once again, turn the injector valve to the
load position. The handle should be
pointed at a 2 o'clock position.
8.4.15 Once again, insert the needle all the way
into the injection port. Allow the syringe
barrel to lay on the black rest. Slowly
inject 200 pL of standard observing that
liquid will drip into the waste beaker.
Leave the syringe in this position.
8.4.16 Once again, carefully, but deliberately
turn the injection valve to the inject
position at 4 o'clock. The run
automatically begins and will stop in 6.0
mi nutes.
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8.4.17 You should still be in the PREPARE TO
INJECT form. Remember, you can the view
the chromatography in a real time mode bv
pressing F3 CMONITOR]. After 6.0 minutes.
press F8 [EXIT] to return to the PREPARE TO
INJECT form.
8.4.18 Using the return key, move the highlighted
area adjacent to the Data File Name form
(See Form E10). Type UNKN0WN5.D. Press
the return key. This will create a new
file name. This is the name of your
raw data file for your unknown sample
i n j ecti on .
8.4.19 Remove the syringe from the injection port.
8.4.20 Rinse the syringe well with methanol.
8.4.21 Fill a 250 pL Hamilton syringe with
unknown sample, prepared in section 7.
8.4.22 Inject the sample repeating steps
B.4. 14 thru 8. 4.20.
8.4.23 You should still be in the PREPARE TO
INJECT form. Remember, you can view the
chromatography in a real time mode by
pressing F3 [MONITOR]. After 6.0
minutes press F8 [EXIT! to return to the
PREPARE TO INJECT form.
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FORM ElO
PREPARE TO INJECT
ta File Name XANTHSTD2 .D :
Flow 1.500 0.000 ml/min
Solvent A 100.0 0.0 X
B 0.0 0.0 X
CI 0.0 0.0 X
Max Pressure 400 1 bar
Stop Time 6.00 0.00 min
7 May 88 4:52 pm
overwrite
: narrow
Contacts : 0000 0000
LC PRERUN
DAD PRERUN
** Enter a filename of up to 8 characters or
'?'
to list a disc volume **
"mMONITOR
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8.4.24 You are now done with the analvsis part of
this laboratory procedure.
8.5 Calculate the Area Under the Peaks
8.5.1 You should still be in the PREPARE TO
INJECT form. Return to the top level
screen by pressing F8 [QUIT].
8.5.2 Press F3 [DATA EDITOR]. This is the area
where you may review your data, acquire
chromatograms, review retention times and
electronically acquire peak area data
(integrate) needed for quantitative work.
8.5.3 The first form you observe will prompt you
to type a file name. Type XANSTD1.D and
press return. The computer will display
the chromatogram obtained for that sample.
8.5.4 Go to the next form by pressing F4 [INTEG
KEYS].
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8.5.5 Press F3 Clnteg.l. The area under each
of your peaks will be electronically
calculated (integrated).
8.5.6 Press the shift and print keys
simultaneously to get a hard copy of your
integrated chromatogram displayed in this
form.
8.5.7 Press F4 [List Int Results] to obtain your
integrated data.
8.5.8 Press F5 [Send to Printer] to obtain a hard
copy.
8.5.9 Press F8 CStop Tabulate] to go to the
previous form.
8.5.10 Press F8 [EXIT]. This will allow you to go
to a form that will allow you to change
your data file name.
8.5.11 Press Fl [New Data File]. You will again be
prompted to type a file name. Type
XANSTD2.D and press return. The computer
will display the chromatogram obtained for
that sample.
8.5.12 Repeat steps 8.5.4 through 8.5.11. You
now have chromatograms and integrated peak
areas for all of your methylxanthine
standards.
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8.5.13 Repeat steps 8.5.4 through 8.5.11 for
the unknown sample. Remember that the file
name is UNKN0WN5.D.
8.5.14 Press F8 [QUIT]. You are finished with the
data editor. You should now have
chromatograms and integrated peak areas
for the 3 samples injected in section 8.4
(See Figures 19-21).
Instrument Shut-down
9. 1 Flushing Out the System
9.1.1 Turn off the pump by using the on/off
buttons on the panel in the front of the
mainframe LC.
9-1.2 Switch the eluent bottle you have been
using with one containing HPLC-grade water.
9.1.3 Turn the pump on. Flush the system and
column for 10 minutes.
9.1.4 Turn off the pump .
9-1.5 Switch this water bottle with the one
containing 107. v/v methanol prepared in
section 4.5.
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FIGURE 19
Chromatogram and Intergrated Peak Area for Methylxanthine
Standard Level 1
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FIGURE 20
Chromatogram and Intergrated Peak Area for Methylxanthine
Standard Level 2
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T: LC A 210,4 550,100
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X: null.
LC A 210,4
XANSTD2.D
550,100 of XANSTD2.D
Peak*
1
2
3
4
Ret Time
2.653
3.380
3.752
5.229
Type
BB
Bv
\)B
BB
Width
0.065
0.081
0.094
0.124
Area St ar t Tine En d Tine
664.82 2.497 2.923
836.75 3.178 3.593
479.78 3.593 4.051
721 .50 4.914 5.595
E33
FIGURE 21
Chromatogram and Intergrated Peak Area for Un k nown
Sample Mix of Methyl xanthi nes
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Peak* Ret Tine Type Width Area St ar t Tine En d Tine
1 2.633 BB 0.065 322.98 2.483 2.845
2 3.356 BV 0.081 321.22 3.207 3.547
3 3.724 VB 0.093 468.35 3.547 3.995
4 5.185 BB 0.122 364.73 4.921 5.507
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9-1.6 Turn the pump on. Flush the system and
column for a minimum of 10 minutes.
9. 2 Shutting Down the System
9.2.1 Turn all the electrical components off in
exactly the reverse order that you turned
them on.
9.2.2 Be sure that the switch on the 6 outlet
power strip has been turned off.
10. Cal cul ati ons
10. 1 Component Identification
Elution Order Compound Retention Time (min)
1 Theobromine 2.64
2 Theophylline 3.37
3 (3-Hydroxethyl theophyl 1 i ne 3.74
4 Caffeine 5.21
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10-2 Peak Area Ratio (PAR). A separate peak area rati
must be calculated for every compound in every
i n j ect i on .
o
PARix =
Aix
Ais
Where PARix = The peak area ratio for a
compound (x) within a sample
i n jecti on ( i > .
Where Aix = The peak area of a compound
(x) within a sample injection
(i ) .
Where Ais = The peak area of the
internal standard (s) within
a sample injection (i>.
10.3 Response Factor (Rf). A separate response factor
must be calculated for every compound.
Ci x
Rfix =
PARix
Where Rfix = Response factor for a compound (x)
in standard (i) level 1 or 2.
Where Cix = Concentration fpg/mL> of a
compound (x) in standard (i) level 1 or
2 prepared in section 6. 1 or 6.2.
10.4 Average Response Factor (RF) of Standard Level 1
and 2
Cix C2x
PARix PAR2x
RFx = -
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Where RFx = The average response factor of
standard level 1 and 2 of a compound
(x) .
Where Cix = The Concentration (yg/mL) of a
compound (x) in standard level 1.
Where C2x = The Concentration (ug/mL) of a
compound (x) in standard level 2.
Where PARix = The peak area ratio of a compound
(x) in standard level 1.
Where PAR2x = The peak area ratio of a compound
(x) in standard level 2.
10.5 Calculate the Concentration of a Compound in the
Unknown Sample
Cux = (RFx) (PARux)
Where Cux = The unknown concentration of a
compound (x) within the unknown sample
mix (u) prepared in section 7.
11. Sample Calculations (Data collected from Figures 19-21)
Peak #1 Compound Aix A2x Aux
2 Theophylline 154 837 321
3 Internal Std 464 480 468
11.1 Calculation of the Peak Area Ratios
Aix
PARix =
Ais
11.1.1 PAR for theophyl 1 1 ine standard level 1
154
= = 0.332
464
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11.1.2 PAR for theophylline standard level 2
837
480
= 1.744
11.2 Calculation of the Response Factors (Rf)
Ci x
Rfix =
PARix
11.2.1 Response factor for theophylline standard
level 1
5.0 pg/mL
0.332
15.06
11.2.2 Response factor for theophylline standard
level 2
25.0 yg/mL
1.744
= 14.33
11.3 Calculation of the Average Response Factor (RFx)
Rfix + Rf2x
RFx =
11.3.1 Calculation of the RFx for theophylline
15.06 + 14.33
= 14.70
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11.4 Calculation of the Theophylline Concentration in
Unknown Sample
321
PARix = = 0.686
468
(RFx) (PARix) = (14.70) (0.686) = 10.1 ug/mL
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F. Simultaneous Hi gh-Per f ormance Liquid Chromatographic
Analysis of Tricyclic Antidepressant Drugs
1 . Introduct i on
1.1 Trimipramine, doxepin, ami tri ptyl i ne, imipramine,
nortriptyline, and desipramine are tricyclic
compounds studied in this investigation. They
possess antidepressant activity that can be used to
treat mental depression. They are all structurally
similar. All these compounds contain a secondary
or tertiary amine group which is attached to the
middle ring of a 3 ring molecular core.
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2. Purpose
2.1 HPLC is a valuable analytical tool available for
the determination of blood and plasma levels of
tricyclic antidepressants. The purpose of this
laboratory procedure is to familiarise the
clinical chemistry student with the basic operation
of a semi -automated high-performance liquid
chromatograph so that he can gain experience with
this separation technique and learn some
practical analytical skills.
3. Summary of Method
3.1 Trimipramine, doxepin, ami tri ptyl i ne, imipramine,
nortriptyline, and desipramine are dissolved in
eluent and chromatographed on an Alltech CN bonded
phase cartridge column. The HPLC separation is
done i socrati cal ly (a single eluent system), in the
reverse-phase mode. Mixtures of the drugs are
differentially partitioned on this column and
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clearly resolved. Spectrophotometry detection is
performed at 215 nm. Quantitation is done by
mathematically comparing detector response of drug
standards to unknowns. Promazine, the internal
standard, is added to each sample at a constant
level so that small variations in technique, such
as injection, can be corrected.
Materials and Reagents
4. 1 Apparatus
4.1.1 A Hewlett-Packard high-performance liquid
chromatographic system was used for all
analytical work (Hewlett Packard,
Avondale, PA 19311-0900). The major
components housed within the mainframe of
this HP 1090 Series M liquid chromatograph
are an HP 1040M photodiode array detector, a
PV5 ternary solvent delivery system, and a
Rheodyne model 7010 manual injection valve.
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This system is controlled and monitored by
an HP 79994A Analytical Chemstation. The
central part ox this Chemstation is the HP
9000 Series 300 computer. Other important
components included an HP 9153B 20 megabyte
Winchester disc drive with a separate disc
drive for 3.5 inch flexible discs, an HP
35741A color video monitor, keyboard, and an
HP 2225A Thinkjet printer. HP 79995A,
revision 3.11 operating software is also
used .
4.1.2 An Alltech Econosphere CN, 5 pm 150 mm
X 4.6 mm i.d. analytical cartridge column
was used (Alltech Associates, Inc.,
Deerfield, IL 60015., C/N. 35621).
4.1.3 An Alltech CN guard cartridge column
was used to protect the analytical
column (Alltech Associates, Inc., C/N.
28023) .
4.1.4 Ranin model P-100 and P-1000 digital
pipettes were used. (Ranin Instrument
Company Inc., Woburn, MA 01801).
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4-2 Stock Reagents (All reagents are available from the
stockroom)
4.2.1 HPLC-grade water.
4.2.2 HPLC-grade methanol (MEOH).
4.2.3 HPLC-grade acetonitrile (ACN).
4.2.4 HPLC-grade isopropyl alcohol ( IPA) .
4.2.5 Reagent grade monobasic potassium
phosphate (KH2P04).
4.2.6 Reagent grade Potassium hydroxide (KOH).
4.2.7 Trimipramine Maleate (Sigma Chemical
Company. St. Louis Mo 63178. Sigma No.
T-3146) .
4.2.8 Doxepin HCL (Sigma Chemical Company.
Sigma No. D-4526) .
4.2.9 Ami tr i ptyl i ne HCL (Sigma Chemical Company.
Sigma No. A-8404) .
4.2.10 Promazine HCL (Sigma Chemical Company.
Sigma No. P-6656).
4.2.11 Imipramine HCL (Sigma Chemical Company.
Sigma No. 1-7379) .
4.2.12 Nortriptyline HCL (Sigma Chemical Company.
Sigma No. N-7261 ) .
4.2.13 Desipramine HCL (Sigma Chemical Company.
Sigma No. D-3900) .
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4.3 Stock 2.5 N KQH. (lOOmL)
4.3.1 Add 14.0 g of KOH to a 100 mL volumetric
flask.
4.3.2 Add HPLC-grade water to the 100 mL mark.
4.3.3 Mix by inversion until completely dissolved.
4.4 Stock 0.012 M Potassium Phosphate Buffer. pH 6.7
( ID
4.4.1 Add 1.63 g of KH2P04 into a IL graduated
cyl inder .
4.4.2 Add HPLC-grade water to the 950 mL mark.
4.4.3 Stir until completely dissolved.
4.4.4 Adjust pH to 6.7 with 2.5 N NaOH (about
3 mL) .
4.4.5 Add HPLC-grade water to the IL mark.
4.5 Eluent (ID 177. Stock Buffer (0.012 M KH2P04)
407. ACN
437. MEOH
4.5.1 In a IL graduated cylinder, add 170 mL of
the 0.012 M stock buffer prepared in section
4.4.
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4.5.2 Add 400 mL of HPLC-grade ACN.
4.5.3 Add 430 mL of HPLC-grade MEOH.
4.5.4 Mix well, place in a IL HP solvent reservoir
bottle and degas under vacuum in a sonic-
bath for 1 minute.
4-6 Column Storage Solution (ID 107. v/v MEOH
4.6.1 In a IL graduated cylinder, add 100 mL of
HPLC-grade MEOH.
4.6.2 Add HPLC-grade water up to the IL mark.
4.6.3 Mix well, place in a IL HP solvent reservoir
bottle and degas under vacuum in a sonic-
bath for 1 minute.
5. Stock Standards
5.1. Trimipramine Standard. 1.0 mg/mL (25 mL)
5.1.1 Weigh 34.9 mg of trimipramine maleate into a
25 mL class A volumetric flask.
5.1.2 Add MEOH to the mark and dissolve
completel y .
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5. 2 Doxepin Standard. 1.0 mg/mL (25 mL)
5.2.1 Weigh 28.3 mg of doxepin HCL into a 25 mL
class A volumetric flask.
5.2.2 Add MEOH to the mark and dissolve
compl etel y.
5.3 Amitriptyl ine Standard. 1.0 mg/mL (25 mL)
5.3.1 Weigh 28.3 mg of ami tri ptyl i ne HCL into a
mL class A volumetric flask.
5.3.2 Add MEOH to the mark and dissolve
compl etel y .
5. 4 Promazine Internal Standard. 1.0 mg/mL (25 mL)
5.4. 1 Weigh 28.2 mg of promazine into a 25 mL
class A volumetric flask.
5.4.2 Add MEOH to the mark and dissolve
compl etel y -
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5.5. Imipramine Standard. 1.0 mg/mL (25 mL)
5.5.1 Weigh 28.2 mg of imipramine HCL into a 25 mL
class A volumetric flask.
5.5.2 Add MEOH to the mark and dissolve
compl etel y .
5.6. Desipramine Standard, 1.0 mg/mL < 25 mD
5.6.1 Weigh 28.4 mg of desipramine into a 25 mL
class A volumetric flask.
5.6.2 Add MEOH to the mark and dissolve
compl etel y -
6. Preparation of Working Tricyclic Antidepressant Drug
Standards for Calibration (10 mL)
6. 1 Level 1. Trimipramine, Doxepin. Ami tri ptyl i ne,
Imipramine. Nortriptyline. Desipramine at 2.0
uo/mL and Promazine at 4.0 ug/mL
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6.1.1 Add 50 pL of each of the stock 1.0 mg/mL
stock trimipramine, doxepin, ami tri ptyl i ne,
imipramine, nortriptyline, and desipramine
standards to a 25 mL class A volumetric
flask using an appropriate pipette.
6.1.2 Add 100 pL of the stock 1.0 mg/mL
promazine (internal standard) to this 25 mL
class A volumetric flask using an
appropriate pipette.
6.1.3 Add eluent (prepared in section 4.5) to the
25 mL mark. Mix by inversion.
6. 2 Level 2, Trimipramine, Doxepin, Ami tri ptyl i ne.
Imipramine, Nortriptyline. Desipramine at 10.0
UP/mL and Promazine at 4.0 pg/mL
6.2.1 Add 250 pL of each of the stock 1.0 mg/mL
stock trimipramine, doxepin, ami tr i ptyl i ne,
imipramine, nortriptyline, and desipramine
standards to a 25 mL class A volumetric
flask using an appropriate pipette.
6.2.2 Add 100 pL of the stock 1.0 mg/mL
promazine (internal standard) to this 25 mL
class A volumetric flask using an
appropriate pipette.
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6.2.3 Add eluent (prepared in section 4.5) to the
25 mL mark. Mix by inversion.
7. Preparation of an "Unknown" Sample for Analysis
7-1 Add 100 pL of each of the stock 1.0 mg/mL
stock trimipramine, doxepin, ami tri ptyl i ne,
imipramine, nortriptyline, desipramine, and
promazine standards to a 25 mL class A
volumetric flask using an appropriate
pipette.
7.2 Add eluent (prepared in section 4.5) to the
25 mL mark. Mix by inversion.
8. Anal ysi s
8. 1 Equipment Set-up
8.1.1 HP1090M and Workstation should be correctly
installed, configured, and operational. If
the system is not operational, refer to the
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appropriate operators' manuals (42-45).
8.1.2 The solvent delivery system (SDS) should
already have been primed. If the solvent
system is not operational, refer to the
appropriate sections in the operator's
manual (46). This is usually done by pumping
degassed IPA through each solvent line at
5.0 mL/min for 3-5 minutes.
8.1.3 Load the degassed eluent prepared earlier
into the solvent compartment section
farthest to the left (pump A).
8.1.4 Install the appropriate guard cartridge and
analytical cartridge column.
8. 2 Instrument Start-up
8.2.1 Turn on the electrical power to the
analytical workstation by switching on the
tan 6 outlet power strip located along the
wall behind the computer.
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8.2.2 Turn on the electrical power to the
mainframe HPLC by pressing the POWER-ON
button located on the front panel in the
lower '-ight corner.
8.2.3 Turn on the diode array detector (DAD) by
pressing the DETECTOR-ON button located
on the same panel. The deuterium lamp
requires 15-30 minutes warm-up time.
8.2.4 """urn on the Think Jet Printer. (The switch
is located in the back right corner).
8.2.5 Turn on the 20 MB hard drive (9153B) by
depressing the rectangular button located in
front on the left side.
8.2.6 Turn on the CRT by depressing the
rectangular button located in front on the
lower left side.
8.2.7 Turn on the computer by depressing the
rectangular button located in the front on
the lower left side. Several screens
should automatically be displayed on the
CRT screen, indicating that memory is being
loaded, tested, and that the system is
booted .
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8.2.8 The system should now be -fully operational.
All operations and commands can now be
controlled from the keyboard. pIease note
the keys labeled fl-fS across the top of
the keyboard. They are essential to the
operation of this system and will be used
frequently to initiate operations described
in the green boxes viewed across the
bottom of the CRT screen. Each screen
viewed is called a form, which contains
several functions that can be initiated
through commands from the keyboard.
8.2.9 Verify the correct date on the bottom of
the CRT screen. Proceed by pressing the
return key on the keyboard.
8.2.10 Verify the correct time. Proceed by
pressing the return key on the keyboard.
8.3 Getting Ready to Run an Analvsis - You are now in
the [Top Level] of a hierarchial tree of
functions (See Form Fl).
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FORM Fl
HP 79994A
HPLC WORKSTATION
for HP 1040M
and HP 1090M
Copyright 1985, Hewlett-Packard Company
[TOP LEVEL]
: Run-:
Method
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8.3.1 Press F2, CData Acquisition] to load the
data acquisition program.
8.3.2 The next screen (form) is the PREPARE TO
INJECT form (See Form F2) . Press F6. CEDIT
PARAMS].
8.3.3 You are now in the FILE INFORMATION form.
If the tricyclic antidepressant drug
parameter file is not loaded (See Form F3> ,
press Fl CLoad Paramsl. You will be
prompted to type the name of a parameter
file (See Form F4) .
8.3.4 Type DATA:TRICY.A over the previously
loaded parameter file name (See Form F5).
Press return. All the proper operating
parameters needed to assay the tricyclic
antidepressants will be automatically
loaded. This includes the proper flow of
the pumps, run time, and detector wavelength
setti ngs.
8.3.5 Turn on the SDS by pressing the PUMP ON
button at the front panel on the mainframe
of the HPLC. The column will need to
equilibrate for 10 minutes.
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FORM F2
PREPARE TO INJECT
Data File Name : DATA.-TEST1.D
Flow \mrm 0.000 ml/min
Solvent A 100.0 0.0 X
i 0.0 0.0 X
cT O.O O.O X
7 May 88 12:32 pm
overwri te
: narrow
Max Pressure : 400 1 bar
Stop Time : no limit 0.00 min
Contacts : 0000 0000
LC PRERUN
DAD PRERUN
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FORM F3
FILE INFORMATION
PARAMETER FILE
Param. File Name DATA:TEST.A
Last Change Date 10 Apr 88 2:10 am
information :
Last~A]tered By :
DATA FILE
Data File Name DATAiTESTl.D
Operator Name :
Sample Name :
Further Comments :
PARAMS I PARAMS
F18
FORM F4
FILE INFORMATION
PARAMETER FILE
Param. File Name
Last Change Date 10 Apr 88 2:10 am
information :
Last Altered By :
DATA FILE
Data File Name DATA:TEST1.D
Operator Name
Sample Name
Further Comments
Load Parameter File - Enter a File Name or type '?' to list a disc volume
Escape-
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FORM F5
FILE INFORMATION
PARAMETER FILE
Param. File Name DATA: TRI CY. A
Last Change Date 7 May 88 5:24 pm
Information : 17X(12mM KH2P04.PH6.7), 40JACN, 43XME0H, CN, 215NM
LasfAltered By : GREGG C. HIDER
DATA FILE
Data File Name TEST1.D
Operator Name : STUDENT
Sample Name :
Further Comments : GETTING READY TO RUN A SAMPLE
TRICYCLIC ANTIDEPRESSANT DRUGS
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8.3.6 You should still be in the FILE INFORMATION
form. Pressing F5 LLC PARAMS] will ailow
you to verify that the proper LC settings
are loaded (See Form F6). The A pump flow
should be set to 2.5 mL/min and the run
stop time should be 8.5 minutes. Press F8
to ex i t .
8.3.7 You should still be in the FILE INFORMATION
form. Pressing F6 CDAD PARMS] will allow
you to verify that the detector is set at
the proper settings. The A signal should
be set to 215 nm (See Form F7) .
8.3.8 Press F8 to exit. You should still be in
the FILE INFORMATION form.
8.3.9 Press F8 LEXIT].
8. 4 Running an Analysis
8.4.1 You should now be in the PREPARE TO
INJECT form. Press the return key several
times until the highlighted area is moved
adjacent to the Data File Name field (See
Form F8> .
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LIQUID CHROMATOGRAPH initial parameters
Flow
Solvent A
B
CI
jJ2 ml,''min
100.0 I
off
off : narrow
Max Pressure 400 bar Min Pressure : off
Stop Time
Post Ti me
8.50 min
O.00 mm Contacts : 0000
LC.TIHE
TABtev
-QRM FT
DIODE-ARRAY DETECTOR
B C D E
off off gjj off
SIGNALS A
Sample (nm)
Wavelength : 215
Bandwidth : 4
Reference Inm)
Wavelength : 550
Bandwidth : 100
signals & spectra
I- G
off off
H
off
Store Spectrum : peak controlled
Threshold : 10.0 mAU
Peakwjdth
Stop Time
0. 100 min
same as LC
abou t Records acquired durina Run
Samp] i not Interval 640 ms
Spectrum Range from : 190 nm
to : 600 nm
** Press <on> or <off> to set Signal
FORM F8
PREPARE TO INJECT
Data File Name :
Flow
Sol ven t A
B
Ci
DATA:TEST1.D
2.500 0.000 ml/min
100.0 0.0 5
off
off
7 May 88 12:57 pm
overwri te
narrow
Max Pressure :
Stop Time :
400 1 bar
6.00 0.00 min
Contacts : 0000 0000
LC PRERUN
DAD PRERUN
** Enter a filename of up to 8 characters or
'?'
to list a disc volume **
Stop| EDIT;
Run- "I PARAMS
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8.4.2 Type TCASTD1.D. Press the return kev-
This will create a new file name. This is
the name of your raw data file for your
first standard injection.
8.4.3 Lift the cover on the HPLC exposing the
manual injector port and valve.
8.4.4 Fill a 250 pL Hamilton syringe with
standard level 1 prepared in section 6.1.
8.4.5 Turn the injector valve to the load
position. The handle should be pointed at a
2 o'clock position.
8.4.6 Insert the needle all the way into the
injection port. Allow the syringe
barrel to lay on the black rest. Slowly
inject 200 pL of standard observing that
liquid will drip into the waste beaker.
You have properly overfilled the 100 pL
fixed sample loop which will reduce the
chances of carry-over from a previous
injection. Leave the syringe in this
posi ti on .
8.4.7 Carefully, but deliberately turn the
injection valve to the inject position.
The handle should be pointed at a 4
o'clock position. A contact closure is
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made and the run automatically begins and
will stop in 8.5 minutes.
8.4.8 You should still be in the PREPARE TO
INJECT form. You can view the
chromatography in a real time mode by
pressing F3 [MONITOR}. After 8.5 minutes,
press F8 [EXIT] to return to the PREPARE TO
INJECT form.
8.4.9 Using the return key, move the highlighted
area adjacent to the Data File Name field
(See Form F9) .
8.4.10 Type TCASTD2.D. Press the return key.
This will create a new file name. This is
the name of your raw data file for your
second standard injection.
8.4.11 Remove the syringe from the injection port.
8.4.12 Rinse the syringe well with methanol.
8.4.13 Fill a 250 pL Hamilton syringe with
standard level 2 prepared in section 6.2.
8.4.14 Once again, turn the injector valve to the
load position. The handle should be
pointed at a 2 o'clock position.
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FORM F9
PREPARE TO INJECT
Data File Name
Flow
Solvent A
B
Ci
TCASTD1.D.
2.500 0.000 ml /mm
100.O 0.0 %
off
off
7 May 88 5:27 pm
overwri te
: narrow
Max Pressure : 400 0 bar
Stop Time : 8.50 0.00 min
Contacts 0000 0000
LC PRERUN
DAD PRERUN
* Enter a filename of up to 8 characters or
"?'
to list a disc volume **
MONITOR
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8.4.15 Once again, insert the needle all the way
into the injection port. Allow the syring
barrel to lay on the black rest. Slowly
inject 200 pL of standard, observing
that liquid will drip into the waste
beaker. Leave the syringe in this
posi ti on .
8.4.16 Once again, carefully, but deliberately,
turn the injection valve to the inject
position at 4 o'clock. The run
automatically begins and will stop in 8.5
mi nutes.
8.4.17 You should still be in the PREPARE TO
INJECT form. Remember, you can view
the chromatography in a real time mode by
pressing F3 CM0NIT0R]. After 8.5
minutes, press F8 [EXIT] to return to the
PREPARE TO INJECT form.
8.4.18 Using the return key, move the highlighted
area adjacent to the Data File Name form
(See Form F10) . Type UNKN0WN6.D. Press
the return key. This will create a new
file name. This is the name of your
raw data file for your unknown sample
i n j ecti on .
e
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FORM FIO
PREPARE TO INJECT
File Name TCASTD2.D
Flow
SolvenT A
B
ci
2.500 0.000 ml/min
100.0 0.0 X
off
off
7 May 88 5:28 pm
overwrite
: narrow
Max Pressure : 400 3 bar
Stop Time : 8.50 0.00 mm
Contacts : 0000 0000
LC PRERUN
DAD PRERUN
** Enter a filename of up to 8 characters or
'?' to list a disc volume **
MONITOR
EDIT
PARAMS
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8.4.19 Remove the syringe from the injection port
8.4.20 Rinse the syringe well with methanol.
8.4.21 Fill a 250 pL Hamilton syringe with
unknown sample, prepared in section 7.
8.4.22 Inject the sample repeating steps
8.4. 14 thru 8.4.20.
8.4.23 You should still be in the PREPARE TO
INJECT form. Remember, you can the
view the chromatography in a real time
mode by pressing F3 [MONITOR]. After 8.5
minutes press F8 [EXIT] to return to the
PREPARE TO INJECT form.
8.4.24 You are now done with the analysis part of
this laboratory experiment.
8. 5 Calculate the Area Under the Peaks
8.5.1 You should still be in the PREPARE TO
INJECT form. Return to the top level
form by pressing F8 [QUIT].
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8.5.2 Press F3 [DATA EDITOR]. This is the area
where you may review your data, acquire
chromatograms, review retention times and
electronically acquire peak area data
(integrate) needed for quantitative work.
8.5.3 The first form you observe will prompt you
to type a filename. Type TCASTD1.D and
press return. The computer will display
the chromatogram obtained for that sample.
8.5.4 So to the next form by pressing F4 [ INTE6
KEYS].
8.5.5 Press F3 [Integ.]. The area under each of
your peaks will be electronically
calculated (integrated).
8.5.6 Press the shift and print keys
simultaneously to get a hard copy of your
integrated chromatogram displayed in this
form.
8.5.7 Press F4 [List Int Results! to obtain your
integrated data.
8.5.8 Press F5 [Send to Printer] to obtain a hard
copy.
8.5.9 Press F8 [Stop Tabulate] to go to the
previous form.
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8.5.10 Press F8 [EXIT]. This will allow you to go
to a form that will allow you to change
your data file name.
8.5.11 Press Fl [Mew Data File]. You will again
be prompted to type a file name. Type
TCASTD2.D and press return. The computer
will display the chromatogram obtained for
that sample
8.5.12 Repeat steps 8.5.4 through 8.5.11. You
now have chromatograms and integrated peak
areas for all your barbiturate standards.
8.5.13 Repeat steps 8.5.4 through 8.5.11 for
the unknown sample. Remember that the file
name is UNKN0WN6.D.
8.5.14 Press F8 [QUIT]. You are finished with the
data editor. You should now have
chromatograms and integrated peak areas
for the 3 samples injected in section 8.4
(See Figures 22-24).
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FIGURE 22
Chromatogram and Intergrated Peak Areas for Tricyclic
Antidepressant Drugs, Standard Level 1
LC R 215,4 552, 1 QQ Df TCRSTD1 D
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LC ft 215,4
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550,100
T: LC A 215,4 550,100
Z: LC A 215,4 550,100
Y: null.
X: null.
of TCASTD1 .D
Peak*
1
2
3
4
5
e
7
Ret Time
1 .807
2.199
2.3G3
2.B93
2.928
6.005
7.396
Type
BB
BU
VV
VV
VB
BB
BB
Width
0.071
0.088
0.088
0.098
0. 106
0.175
0.208
Area St art Time End Time
268.65 1 .653 2.015
439.85 2.036 2.289
403.58 2.289 2.558
339.99 2.558 2.829
284.45 2.829 3.208
418.47 5.S37 6.404
303.80 7.011 7.842
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FIGURE 23
Chromatogram and Intergrated Peak Areas for Tricyclic
Antidepressant Drugs. Standard Level 2
LC
3BB
2BB
1BB-
R 215.4 55B, 1 BB
as
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OS
of TCBSTD2 . D
u. _l L ' I
[Integl]
B
Tl me C rn 1 n . J
T: LC A 215,4 550,100
Z: LC A 215,4 550,100
Y: null.
X: null.
LC A 215, 4 550 100 of T
TCASTD2.D
Peak* Re t Time Type Width
1 1 .802 BV 0.073
n
L. 2.190 VV 0.089
3 2.352 VV 0.094
4 2.709 VV 0.098
5 2.915 VB 0.112
6 6.003 BB 0.194
7 7.420 BB 0.234
Area
1293
2126
1959
339.
1405
1953
142E
46
Start Time End Time
1 .613 2.018
2.018 2.283
2.283 2.583
2.583 2.816
2.816 3. 264
5.555 6.535
6.982 8.047
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FIGURE 24
Chromatogram and Intergrated Peak Areas for Unknown
Sample Mix of Tricyclic Antidepressant Drugs
LC R 215
14B
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IBB
BB
BB
4B-
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LA.
55B. 1 BB of UNKNOWNS. 0
JA.
in
T1 ins
4
C tn 1 n .
T: LC A 215,4 50, 100
[In teal]
Z: LC A 215,4 550,100
Y: null.
X: null.
LC A 215 ,4 550 100 of UNKN0WN6. D
UNKN0WN6 D
Peak* Ret Time Type Width Area Start Time End Time
1 1 .815 BB 0.072 567.30 1 .610 2.025
n
c. 2.210 BV 0.089 914.44 2.057 2.302
3 2.375 VV 0.091 842.08 2.302 2.590
4 2.720 VV 0.099 337.29 2.590 2.844
5 2.945 VB 0.109 596.01 2.844 3.261
6 6.045 BB 0.182 862.61 5.636 6.510
7 7.454 BB 0.216 610.54 7.032 7.969
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9. Instrument Shut-down
9. 1 Flushing Out the System
9.1.1 Turn off the pump by using the on/off
buttons on the panel in the front of the
mainframe LC.
9-1.2 Switch the eluent bottle you have been
using with one containing HPLC-grade water
9.1.3 Turn the pump on. Flush the system and
column for 10 minutes.
9.1.4 Turn off the pump .
9-1.5 Switch this water battle with the one
containing 107. v/v methanol prepared in
secti on 4.5.
9.1.6 Turn the pump on. Flush the system and
column for a minimum of 10 min.
9. 2 Shutting Down the System
9.2.1 Turn all the electrical components off in
exactly the reverse order that you turned
them on.
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9.2.2 Be sure that the switch on the 6 outlet
power strip has been turned off.
10. Calculations
10.1 Component Identification
Retention Time (min)
1.81
2.20
2.36
2.71
2.93
6.02
7.43
10.2 Peak Area Ratio (PAR). A separate peak area ratio
must be calculated for every compound in every
i n j ect i on .
El uti on Or der Compound
1 Tri mi pr ami ne
2 Doxepi n
3 Ami tri ptyl i ne
4 Promaz i ne
5 Imi prami ne
6 Nortr i ptyl i ne
7 Desi prami ne
PARix =
Aix
Ais
Where PARix = The peak area ratio for a
compound (x) within a sample
i n j ecti on ( i > .
Where Aix = The peak area of a compound
(x) within a sample injection
(i ) .
Where Ais = The peak area of the
internal standard (s) within
a sample injection (i>.
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10.3 Response Factor (Rf). A separate response factor
must be calculated for every compound.
Cix
Rfix =
PARix
Where Rfix = Response factor for a compound (x)
in standard (i) level 1 or 2.
Where Cix = Concentration (pg/mL) of a
compound (x) in standard (i) level 1 or
2 prepared in section 6.1 or 6.2.
10.4 Average Response Factor (RF) of Standard Level 1
and 2
Cix C2x
PARix PAR2x
RFx = -=
Where RFx = The average response factor of
standard level 1 and 2 of a compound
(x ) .
Where Cix = The Concentration (pg/mL) of a
compound (x) in standard level 1.
Where C2x = The Concentration (pg/mL) of a
compound (x) in standard level 2.
Where PARix = The peak area ratio of a compound
(x) in standard level 1.
Where PAR2x = The peak area ratio of a compound
(x) in standard level 2.
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10.5 Calculate the Concentration of a Compound in the
Unknown Sample
Cux = (RFx) (PARux)
Where Cux = The unknown concentration of a
compound (x) within the unknown sample
mix (u) prepared in section 7.
11. Sample Calculations (Data collected from Figures 22-24)
Peak #1 Compound Aix A2x Aux
1 Trimipramine 269 1293 567
4 Promazine 340 339 337
11.1 Calculation of the Peak Area Ratios
Aix
PARi;
Ais
11.1.1 PAR for trimipramine standard level 1
269
= = 0.791
340
11.1.2 PAR for trimipramine standard level 2
1293
= = 3.814
339
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11.2 Calculation of the Response Factors (Rf)
Rfix
Ci x
PARix
11.2.1 Response factor for barbital standard
level 1
2. 0 pg/mL
0.791
2.528
11.2.2 Response factor for trimipramine standard
level 2
10.0 pg/mL
3.814
= 2.622
11.3 Calculation of the Average Response Factor (RFx)
Rfix + Rf2x
RFx =
11.3.1 Calculation of the RFx for trimipramine
2.528 + 2.622
= 2.575
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11.4 Calculation of the trimipramine concentration in
Unknown Sample
567
PARix = = 1.682
337
(RFx) (PARix) = (2.575) (1.682) = 4.3 pg/mL
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